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Structural Characterization of the Dynein-Dynactin Interaction
2013, December
GGNB Science Day, Göttingen, Germany
Structural Characterization of the Dynein-Dynactin Interaction

Abstract
In eukaryotic cells many biological processes like cell division, the distribution of vesi-
cles and organelles require the dynamic rearrangement of molecules and cellular compo-
nents. These rearrangements are controlled by three superfamilies of motor proteins,
which move along the cytoskeletal tracks. One of these motors is the cytoplasmic
dynein complex, which exclusively moves along microtubules towards the minus-end
thereby transporting cargo from the cell periphery back to the cell centre (retrograde
transport). In order to adapt to the diverse cargoes dynein interacts with various
proteins. One of them is dynactin, a large complex that is involved in almost every
dynein function. The interaction of both complexes occurs between the N-terminus of
two dynein intermediate chains (IC) and a coiled-coil region in the dynactin DCTN1
dimer.
For the characterization of the dynein-dynactin interaction chicken DCTN1412-533 and
human N-terminal IC were expressed in tandem in E. coli. Several constructs were
designed in which the IC length varied between 47 and 84 amino acids. Crystal-
lization trials were performed and a condition was found for growing large crystals
with edge lengths of 100-200 µm. X-ray measurements were performed at PETRA III
(DESY, Hamburg) and the best native crystal diffracted to 2.9 Å. Phases were ob-
tained at 3.4 Åusing the single anomalous diffraction approach and crystals consisting
of selenomethionine-incorporated protein. A model of DCTN1412-533 was built by itera-
tive cycles of manual model building and refinement of the model against the diffraction
data. Surprisingly, the asymmetric unit of the crystal only contained DCTN1412-533 in
coiled-coil conformation without bound IC molecules. The DCTN1412-533 structure be-
longs to the canonical parallel left-handed coiled-coil. Its surface is mainly negatively
charged suggesting an electrostatical interaction with IC, which exhibits an alkaline
pI. Analyses of the N-terminal IC sequence supported an assumption that IC might
not bind as a coiled-coil but rather as separate α-helices onto DCTN1. Cross-linking
studies were performed with BS3 to narrow down the IC binding site on DCTN1. Two
binding regions could be determined, which are mainly negatively charged.
This is the first structural insight into the DCTN1412-533 coiled-coil. Based on the cross-
linking experiments and the assumption of two single ICs binding onto DCTN1 several
binding models were determined and analysed. A possible model is the interaction of
two IC molecules, which bind parallel to both DCTN1 bindings sites. A parallel/anti-
parallel interaction of the IC molecules is also conceivable. The localization of the
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Eukaryotic cells are subject to a diverse range of biological processes including trans-
port of vesicles, re-localization of organelles and cell division. An active and directed
movement is crucial for these processes. Therefore, cells possess a diverse set of motor
proteins, which move along cytoskeletal tracks.
These motor proteins are represented by the superfamilies of dynein, kinesin, and
myosin. In order to generate motion they hydrolyse ATP in their motor domain. The
conversion of chemical energy into mechanical movement is governed by conformational
changes in the motor domain. This results in the consecutive attachment and detach-
ment of the molecular motor from the cytoskeleton leading to directional motion along
the tracks (Schliwa and Woehlke, 2003).
The short-range transport along actin filaments is executed by the myosin family, which
mainly move towards the fast growing plus-end (Hartman and Spudich, 2012). Dyneins
and kinesins on the other hand are necessary for the long-range transport using mi-
crotubules. Kinesins are mainly plus-end directed motor proteins moving cargo from
the centre to the cell periphery, which is called anterograde transport (Hirokawa et al.,
2009). Dynein moves exclusively to the minus-end of microtubules. It is responsible
for the retrograde transport from the cell periphery back to the cell centre (Roberts
et al., 2013).
While kinesins and myosins share a common ancestor (Kull et al., 1998) dyneins
evolved from the AAA+ superfamily (AAA = ATPases associated with diverse cel-
lular activities) (Neuwald et al., 1999). Furthermore, dynein is characterised by a
higher molecular complexity. The dynein heavy chain (DHC) alone is twice the size of
muscle myosin and even four times the size of conventional kinesin (Asai and Koonce,
2001). Another interesting aspect is the specialization of the different kinesins (15
classes (Hirokawa et al., 2009)) and myosins (35 classes (Odronitz and Kollmar, 2007))
for certain functions in the cytoplasm, which is not found to that extent for dyneins.
For example, myosin Va seems to be necessary for the transport of peripheral endo-
plasmatic reticulum into the dendritic spines of special neuronal cells whereas myosin
3
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XIX is needed for the transport of mitochondria in human cells (Hartman and Spudich,
2012). Examples for kinesin include kinesin-3 motors, which among others transport
synaptic vesicle precursors and together with kinesin-1 motors are involved in the mi-
tochondria transport (Hirokawa et al., 2009). How dynein manages to adapt to all its
different functions in the cell will be explained hereafter.
1.2. Dynein
Dynein was first discovered about 50 years ago as an ATPase in cilia (Gibbons and
Rowe, 1965). It was named after the unit of force, dyne.
The dynein family consists of nine major heavy chain classes, which can be grouped
into two branches, the cytoplasmic and the axonemal dyneins. Cytoplasmic dynein
1 is expressed ubiquitously and is necessary for almost every minus-end directed mi-
crotubule transport in the cell (Kardon and Vale, 2009). Cytoplasmic dynein 2 is
important for assembly of cilia and flagella (Pazour et al., 1999) and the intraflagellar
transport (IFT) in the axoneme towards the cell body. The other seven dyneins are
anchored within the axoneme where they are responsible for the coordinated beating
of cilia and flagella to cause motion (Wickstead and Gull, 2007).
1.2.1. Structure of cytoplasmic dynein
Cytoplasmic dynein 1 is often referred to as cytoplasmic dynein. It is a large ≈1.5 MDa
multi-subunit complex consisting of two homodimeric heavy chains (DYNC1H1) each
≈500 kDa as well as various additional subunits (see figure 1.1).
The dynein heavy chain (DHC) is made up of the 10 nm long stalk, followed by a ring
of six AAA+ domains, which is attached to the N-terminal linker and the tail domain.
The latter is responsible for the homodimerization of the two heavy chains and acts as
a scaffold for the assembly of dynein subunits, which bind as dimers. The six AAA+
domains are encoded by a single polypeptide, which is unusual for ATPases (Carter
et al., 2011). Only the first four AAA+ domains (AAA1 to AAA4) contain functional
ATP binding sites. However, only the hydrolysis of ATP in AAA1 is essential for
the movement along microtubules. AAA2-AAA4 can also hydrolyse/bind ATP though
they only seem to influence motility (Kon et al., 2004). From the AAA4 domain the
stalk emerges with the microtubule-binding domain (MTBD) at its tip. This stalk is












Figure 1.1.: Schematic overview of cytoplasmic dynein. The representation
shows the possible composition of subunits. HC - Heavy chain, IC - Inter-
mediate chain, LC8 - Light chain 8, LIC - Light intermediate chain, MTBD
- microtubule-binding domain, robl - Roadblock light chain, TcTex-1 - Light
chain (T-complex testis-specific protein 1)
extending out from the AAA5 domain. It may play a role in transferring the ATP
state of the hexameric AAA+ ring to the MTBD (Carter, 2013).
The linker arches over the surface of the AAA+ ring interacting with AAA5 and AAA1
and goes down next to the AAA1 domain (Carter et al., 2011). It is thought to deliver
the powerstroke (Roberts et al., 2013).
Out of the remaining dynein subunits only two intermediate chains (IC; ≈74 kDa) and
four light intermediate chains (LIC; 50-60 kDa) assemble directly on the N-terminus of
the DHC (Tynan et al., 2000). The smaller light chains (LC) light chain 8 (LC8; ≈8
kDa), roadblock light chain (robl; ≈10 kDa), and T-complex testis-specific protein 1
(TcTex-1; ≈14 kDa) bind as dimers to the N-terminus of the intermediate chain dimer
(see figure 1.2) (Hall et al., 2009, 2010, Makokha et al., 2002, Susalka et al., 2002).
While IC and LIC are only associated with dynein the LCs can be found in connection
with other binding partners (Pfister et al., 2006).
The dimeric roadblock light chain is structurally unrelated to LC8 and TcTex-1. It
is bound by two IC α-helices about 100 residues away from the other two LCs (Hall
et al., 2010). LC8 and TcTex-1 are homologous proteins with similar IC binding sites,
which lie close to each other. While unbound IC is disordered (Benison et al., 2006)
the binding of LC8 and TcTex-1 leads to the formation of extended β-strands of the
5
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recognition sites (Hall et al., 2009). Moreover, the binding of one LC is enhanced when
another LC is already bound to IC (Williams et al., 2007). Hence it is assumed that
these light chains have a polybivalent scaffold, which enhances the affinity of every bi-
valent binding partner like the binding of LCs and coiled-coil interactions (Hall et al.,
2009). This assumption is supported by the finding that the binding efficiency of an
adaptor protein (dynactin DCTN1) to IC containing four bivalent sites is higher in
contrast to IC with only one site (King et al., 2003). Both light chains were known to
have various binding partners and it was presumed that they act as adapters for cargo
binding for the dynein transport. However, recent studies showed the cargo-binding
sites of the IC bound LC8 homodimer are occupied by IC making it impossible to bind
cargo at the same time (Hall et al., 2009). Therefore, it has been suggested that LC8
rather acts as a hub protein promoting the activation and dimerization of its binding
partners, like IC (Barbar, 2008). Besides the interaction sites of LCs, the N-terminus of
IC contains interaction motifs for various other proteins that are necessary for the es-
sential functions of dynein. Amongst others IC binds to the dynactin subunit DCTN1,








Figure 1.2.: Model of the assembly of dynein intermediate chain and its
light chains. The model is a modified image based on the work of Morgan
et al. (2011) and Hall et al. (2010). The structures are derived from NMR and
X-ray experiments using recombinantly expressed D. melanogaster proteins.
Numbers near the bound light chains indicate the amino acids positions of
IC that interact with the respective light chains. The N-terminal numbers
denote IC regions that are necessary for binding to other proteins. grey: IC
- Intermediate chain, red/purple: regions of IC supposedly interacting with
dynactin, blue: robl - Roadblock light chain, green: LC8 - Light chain 8,
yellow: TcTex-1 (T-complex testis-specific protein 1)
Furthermore, it could be shown that mammals have two IC proteins (encoded by
Dync1i1 and Dync1i2 ). Analysis of mouse IC showed that they undergo alternative
splicing at several exons coding for the N-terminal region of the proteins. The expres-
sion of the various isoforms is tissue specific. Most spliced isoforms of both IC proteins
were found in brain-specific tissues which may reflect the complexity of the cargoes
transported in neurons (Kuta et al., 2010).
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1.2.2. Functions of cytoplasmic dynein
Cytoplasmic dynein is necessary for numerous activities in the cell. It plays a ma-
jor role in microtubule organization during mitosis. It could be demonstrated that
injection of antibodies against dynein HC during mitosis led to defects in spindle mor-
phology (Vaisberg et al., 1993) and chromosomes were unaligned when the dynein-
activating protein, dynactin, was disrupted (Echeverri et al., 1996). Together with
other proteins dynein can also be found attached to kinetochores of chromosomes dur-
ing prometaphase. There, it is necessary for capturing microtubules and powering the
movement of chromosomes towards spindle poles before they align on the metaphase
plate (Yang et al., 2007). Additionally, dynein delays anaphase until all chromosomes
are attached to the spindle (Foley and Kapoor, 2013). Then it removes the spindle-
assembly checkpoint proteins by transporting them towards the spindle poles, which
leads to the separation of chromosomes during anaphase (Howell et al., 2001).
Dyneins can also be found attached to the cell cortex applying a pulling force to micro-
tubules by either moving towards the minus-end or binding to a disassembling plus-end
(Hendricks et al., 2012). This leads to a stabilization of microtubule plus-ends and reg-
ulates microtubule dynamics.
Furthermore, dynein is involved in the organisation and localisation of the Golgi as
well as in the minus-end directed transport of endosomes, lysosomes, and lipids to the
cell centre. It also plays a role in the vesicle transport from endoplasmatic reticulum to
the Golgi. Experiments could demonstrate that the disruption of dynein using specific
antibodies lead to the fragmentation of the Golgi (Vaisberg et al., 1996). A disruption
of dynein heavy chain in mice caused a re-localization of lysosomes and endosomes as
well as an inhibition of the vesicle transport from the endoplasmatic reticulum to the
Golgi (Burkhardt et al., 1997, Harada et al., 1998, Presley et al., 1997).
1.3. The activator of dynein: dynactin
In order to achieve all the above mentioned functions dynein interacts with various
adaptors and regulators. One of them is dynactin, which is necessary for almost every
dynein process (Karki and Holzbaur, 1999, Schroer, 2004). Like dynein dynactin is a
large multi-subunit complex (≈1.1 MDa). It is a very ancient protein complex that can
be found in every eukaryotic organism except for plants and diplomonads. The absence
of dynactin in some species coincides with that of the dynein heavy chain. However,
there are some species like Piroplasmida, which encode a divergent and shortened
dynein heavy chain without possessing genes for dynactin. It is not known if these
7
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dynein motors are functional but it shows that the presence of dynactin is coupled to
dynein (Hammesfahr and Kollmar, 2012).
Dynactin was first discovered in 1991 as a cytosolic activity that supported dynein
to move vesicles over a long range along microtubules. Later that same year it could
be attributed to the dynactin complex (Gill et al., 1991, Schroer and Sheetz, 1991).
Electron microscopy analysis revealed two major segments, a helical filament about 10
× 37 nm and a projecting arm about 24 nm in length (Schafer et al., 1994a). The
complex consists of 11 subunits of various sizes in unequal stoichiometry as shown in
















Figure 1.3.: Schematic overview of cytoplasmic dynein activator dynactin.
The complex can be split in two parts, the rigid helical filament and the
flexible arm-shoulder region. The helical filament is comprised of eight actin-
like proteins 1 (Arp1) and one conventional actin. On the barbed-end it is
caped by the capping protein CapZ. On the opposite site it is terminated by
the pointed-end complex comprised of Arp11, DCTN4, DCTN6, and DCTN5.
The protruding arm consists of a DCTN1 dimer, which interacts with four
DCTN2 and two DCTN3 molecules.
The helical structure is a mini actin-filament, which is comprised of actin-related pro-
teins Arp1 (8×) and Arp11 (1×), as well as a conventional actin molecule. Just like
conventional actin, Arp1 is capable of hydrolysing ATP and forming filaments (Bing-
ham and Schroer, 1999). But unlike actin, Arp1 forms very stable, short filaments of
identical length. It is able to bind to organelle-associated β-spectrin III. Therefore,
it is hypothesized to recruit dynein to intracellular membranes for further transport
(Holleran et al., 2001).
The filament is capped on one side with the typical actin-capping protein, CapZ, sug-
gesting an Arp1 structure similar to the barbed (plus) end of actin (Schafer et al.,
8
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1994a,b). It consists of two subunits (Cap32 and Cap34), which despite low sequence
homology exhibit very similar secondary structures (Eckert et al., 2012). On the op-
posing end sits the heterotetrameric pointed-end complex consisting of Arp11, DCTN4,
DCTN5, and DCTN6 (Eckley et al., 1999, Schafer et al., 1994a). Due to the actin-like
sequence of Arp11 this subunit can bind to Arp1, but denies further attachment of
Arp1 molecules. This suggests a capping function for Arp11.
The DCTN4 sequence predicts a zinc-binding RING or LIM motive close to the N-
terminus (Eckley et al., 1999, Karki et al., 2000). These motifs generally participate
in protein-protein interactions. Deletion of the zinc-binding motif did not disrupt the
interaction with ARP1 or actin suggesting a role in binding to other dynactin subunits
or to other subcellular structures (Garces et al., 1999, Vaughan et al., 1999). However,
the absence of DCTN4 does not significantly affect dynactin stability (Lee et al., 2001).
Furthermore, DCTN4 contains a highly conserved C-terminal metal-binding domain
(CXXC), which could play a role in the copper-dependent interaction with an ATPase,
ATP7B. This ATPase is important for maintaining the copper homeostasis in liver
cells. The transport of ATP7B to vesicles of liver cells is necessary for the removal of
excess copper into the bile (Lim et al., 2006).
The two remaining pointed-end complex proteins, DCTN5 and DCTN6, are predicted
to adopt an unusual left-handed β-helical fold leading to the formation of a small tri-
angular prism (Parisi et al., 2004). The recently solved structure of DCTN6 could
confirm this prediction (Yeh et al., 2013). Due to the similar prediction for DCTN5 a
hydrophobic interaction between both proteins based on the DCTN6 structure is pro-
posed. Furthermore, it could be shown that mitotic phosphorylation of DCTN6 during
prometaphase is required for targeting polo-like kinase 1 to kinetochores. This in turn
is important for the attachment of microtubules to the kinetochore (Yeh et al., 2013).
The DCTN5 subunit is required for the dynein-mediated early endosome movement.
Its loss caused early endosome accumulation (Zhang et al., 2011).
The flexible structure protruding from the barbed-end of the Arp1-filament consists of
the three subunits DCTN1, DCTN2 (dynamitin), and DCTN3. DCTN1 is the largest
of all dynactin subunits (≈150 kDa). Each complex features a homodimer consisting of
two DCTN1 molecules, which are predicted to exhibit two coiled-coils (≈50 and 20 nm
in length) interrupted by regions of undefined structure (Gill et al., 1991, Holzbaur
et al., 1991). On the extreme end of the N-terminus is a small globular head with a
CAP-Gly motif (cytoskeleton-associated protein, glycine-rich) that can bind directly
to microtubules in a nucleotide-independent manner (Waterman-Storer et al., 1995).
Together with another microtubule-binding protein, EB1, the CAP-Gly domain forms
a complex to stabilize microtubule plus-ends (Ligon et al., 2003). Next to the CAP-
9
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Gly domain is a basic domain, which could be shown to increase the processivity of
cytoplasmic dynein (Culver-Hanlon et al., 2006). This domain is followed by the first,
≈50 nm long coiled-coil. Since the flexible arm protrudes ≈24 nm out of the helical
filament it is assumed that half of the coiled-coil is contained within the shoulder region
(Schafer et al., 1994a, Schroer, 2004). Furthermore, the first DCTN1 coiled-coil do-
main provides a platform for the binding of several microtubule-based motor proteins.
Here, not only dynein interacts with its activator but also kinesin II (Deacon et al.,
2003) and the kinesin-related motor Eg5 (Blangy et al., 1997). This demonstrates that
dynactin is necessary for the retrograde as well as anterograde transport. The second
coiled-coil domain is assumed to be important for the binding to the Arp1-filament
since it contains a conserved actin-binding motif (Waterman-Storer et al., 1995). This
is supported by the finding that DCTN1 lacking the C-terminus is not incorporated
into the dynactin complex (McGrail et al., 1995). A further essential part of DCTN1
binding to the helical filament is DCTN2. It forms elongated tetramers and probably
self-associates via coiled-coils (Echeverri et al., 1996). Overexpression of this molecule
leads to the disassembly of DCTN1 and DCTN3 from the remaining dynactin com-
plex (Echeverri et al., 1996)(Karki et al., 1998) showing that DCTN2 is necessary for
DCTN1-binding. The exact binding mechanism is unknown but it is speculated that
two C-terminal coiled-coil regions interact with DCTN1 and DCTN3. Furthermore,
DCTN3 plays an essential role in the formation of this subcomplex as it interacts with
DCTN1 and DCTN2 (Terasawa et al., 2010).
1.4. Aim of this work
At present the knowledge about the dynactin complex on an atomic level is limited.
X-ray structures exist for the CAP-Gly domain of DCTN1 (Honnappa et al., 2006),
actin (Otterbein et al., 2001), the subcomplex of the barbed-end capping protein CapZ
(Eckert et al., 2012), and DCTN6 (Yeh et al., 2013). Little else is known about the
other subunit structures and their interactions amongst each other.
In this study the dynein-dynactin interaction site is analysed by applying protein crys-
tallography and chemical cross-linking. Since the discovery of the dynactin complex
several studies have worked on elucidating the binding site. It could be shown that
the extreme N-terminus of the dynein intermediate chain (IC) and the first coiled-coil
of the dynactin subunit DCTN1 are involved in the interaction (Morgan et al., 2011,
Siglin et al., 2013, Vaughan and Vallee, 1995). The interaction sites for both proteins
have been narrowed down by different approaches. NMR experiments could deter-
mine two binding regions in the N-terminal region of IC of Drosophila melanogaster.
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It consists of a helical section between amino acids 1-41 and a nascent helix com-
prised of residues 46-75 (Morgan et al., 2011). The Ph.D. thesis of A. Siglin (2010)
reported a protein gel-shift experiment with recombinantly expressed rat DCTN1-and
IC-fragments of various sizes to identify the minimum sizes of both proteins to form a
complex. It could show that the first 44 amino-acids of IC and amino-acids 415-530 in
the coiled-coil 1 region of DCTN1 are sufficient to form a complex. However, it is still
not understood how they interact on the molecular level.
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2.1. Chemicals and equipment
Chemicals for the preparation of solutions, buffers, and media were purchased from
the companies Carl Roth GmbH & Co. KG (Karlsruhe, D), Sigma-Aldrich
Chemie GmbH (Steinheim, D), and Merck Millipore (Darmstadt, D). Restriction
enzymes and their suitable buffers were acquired from Thermo Fisher Scientific
Fermentas (Vilnius, LIT) and New England BioLabs (Ipswich, US-MA). For
the preparation of plasmid-DNA from Escherichia coli, the extraction of DNA from
agarose gels, and PCR purification, the kits from the company Macherey-Nagel
(Düren, D) were used.
2.2. Strains, plasmids and oligonucleotides
Escherichia coli XL-2 blue (endA1 supE44 thi -1 recA1 gyrA96 relA1 lac) was used




Tetr gal λ(DE3) endA Hte [argU ileY leuW Camr]) was used for expressing the tar-
get proteins.
For the expression of selenomethionine containing proteins methionine auxotroph E. coli
834 cells (hsdS metE gal ompT ) were applied.
Oligonucleotides were synthesized by Eurofins MWG Operon (Ebersberg, D) and












Table 2.1.: List of oligonucleotides
Primer Nucleotide sequence 5’ → 3’ Restriction TM [◦C]
Site
PF1 ATACCATGGGCAGCCAAG TTCAACCAAAATATTTTGAA AAATCTCAA NcoI 51.7
PF2b CCGGGATCCGTCTCAATA TTATACAATTATTACCAATA BamHI 48.0
TAAACATTTGA
PF7 ATACCATGGGCAGCTCTG ACAAAAGTGACTTAAAAGCTGAG NcoI 52.9
PF8b CGCAAGCTTTTACT GAACGGGTTCTTTCTTCTGC HindIII 54.1
PF9 GGTTATGTACAAGGTGCGG AGAAAACGGTCGATGAGGTC BsrGI 58.8
PF10b GAGACGCGTTTACGCCT CCTGCTGACTCATGAGC MluI 58.7
PF8-2 CGCAAGCTTTTATTT CGAGGAGGGAGACATAGG HindIII 52.8
PF7-His-TEV CAGGATCCGGGTGAAAACC TGTATTTTCAGGGCTCT BamHI 52.9
GACAAAAGTGACTTAAAAGCTGAG TEV
PF9-ohneHis ATACATATGGCGGAGAA AACGGTCGATGAGCTG NdeI 58.8
















Table 2.2.: List of plasmids
Plasmid Description Source
pRSFmD1mako 3815 bp; expression vector for Escherichia coli designed from pRSFDuet-1
(Novagen), contains two multiple cloning sites (MCS) for the coexpression of
two target genes, each MCS contains a N-terminal 6× His-Tag (Smith et al.,
1988) and a T7-promoter; RSF origin, kanamycine resistance cassette for se-
lection (see B.1)
PD Dr. Martin Kollmar
Constructs based on aforementioned vector
pMK186 human dynein intermediate chain (DIC)(aa 1-701) in pDXAmako2b Maria Faberova
pMK146b chicken DCTN1 coiled-coil 1 (aa 209-540) in pDXAmako4 Martin Kollmar
pMK220 human DIC (aa 2 - 47) and chicken dynactin DCTN1 (aa 412 - 533) with
N-terminal 6× His-tag cloned into pRSFmD1mako
this study
pMK242 human DIC (aa 2 - 87) and chicken DCTN1 (aa 412 - 533) with N-terminal
6× His-tag cloned into pRSFmD1mako
this study
pMK243 human DIC (aa 2 - 47) with N-terminal 6× His-Tag and TEV restriction site
and chicken DCTN1 (aa 412 - 533) cloned into pRSFmD1mako
this study
pMK248 human DIC (aa 2-69) and chicken DCTN1 (aa 412 - 533) with N-terminal 6×
His-tag cloned into pRSFmD1mako
this study
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2.3. Cloning techniques
2.3.1. Polymerase chain reaction (PCR)
Genes of interest were amplified via polymerase chain reaction (Saiki et al., 1988). For
the amplification the Expand High Fidelity PCR System from Roche Applied Sci-
ence (Penzberg, D) was used. Reactions were set up with 10× PCR buffer supplied by
the company, 2.75 U of the enzyme mix (containing Taq and Tgo DNA polymerase),
0.25 mM of each dNTP, 100 µM of each primer, 2 - 20 ng of template DNA, and water
to add up to a total volume of 50 µl.
PCR reactions were carried out in a PCR Sprint thermal cycler from Hybaid (Ashford,
UK). 20 cycles of denaturation of double-stranded DNA (1 min, 94 ◦C), annealing of
primers to single-stranded DNA (1 min, varying temperature1) followed by an elonga-
tion step (1 min at 72 ◦C) were carried out2. PCR products were checked by applying
5 µl of the reaction sample on a 1% agarose gel.
2.3.2. PCR purification
PCR products were purified from primers, nucleotides, polymerases, and salts with the
NucleoSpin Gel and PCR Clean-up kit (Macherey-Nagel). The company’s manual
was followed.
2.3.3. Restriction digestion of DNA
Plasmids and PCR products were digested for analytical and preparative purposes.
Restriction digests (Nath and Azzolina, 1981) were carried out with restriction en-
donucleases from Fermentas or New England Biolabs and their suitable buffers
for 1 hour at 37 ◦C. The products were analysed on a 1% agarose gel and when necessary
cut out for further cloning (see subsection 2.3.5).
2.3.4. Agarose gel electrophoresis
Prior to gel electrophoresis (Sharp et al., 1973) 6× DNA loading dye (40% Ficoll 400,
0.5% bromphenol blue, 0.5% xylene cyanol) was added to the DNA samples. The
samples were separated together with a DNA marker (GeneRuler 1 kb DNA Ladder,
Thermo Fisher Scientific) according to size in a horizontal agarose gel containing
1% agarose in TAE buffer (40 mM Tris-Cl, 19 mM glacial acetic acid, 1 mM EDTA
1Annealing temperature equals melting temperature of primer minus 5 to 10 ◦C.
2Elongation time depends on fragment length. In 1 min up to 1.5 kb can be amplified, which was
sufficient for all fragments.
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pH 8.0) and ∼ 0.005% ethidium bromide, which intercalates into the DNA and flu-
oresces under UV-light. The gel was run in TAE buffer at 100 V for 60 min and
then the DNA samples were visualized with the UV transilluminator TFX-20M (Life
Technologies, Carlsbad, CA-US).
2.3.5. Gel extraction of DNA fragments
Digested DNA was separated on 1% agarose gels. The desired DNA fragments were
excised from the agarose gels with a clean scalpel for subsequent ligation. After that,
DNA was extracted from the gels with the NucleoSpin® Gel and PCR Clean-up kit
(Macherey-Nagel) following the company’s manual.
2.3.6. Ligation of DNA fragments
For the ligation (Sugino et al., 1977) reaction vector and gel extracted DNA fragments
were mixed in a ratio of 1:3 or 3:5 in a total volume of 10 µl. The incubation took
place in 10× ligation buffer and 5 U T4 ligase (Fermentas) for two hours at room
temperature (∼ 20 ◦C). The reaction sample was then mixed with 50 µl E. coli XL-2
blue.
2.3.7. Plasmid purification
Plasmid purification was performed on colonies derived from ligation and subsequent
transformation into E. coli XL-2 blue. A colony was picked from a LB plate and
inoculated in 3 ml of LB in a culture tube with the appropriate antibiotics and incu-
bated at 37 ◦C, shaking overnight. Then, 1 ml of the culture was centrifuged at 11,000
rcf for 30 seconds. The resulting pellet was used for extracting the plasmid with the
NucleoSpin® Plasmid kit from Macherey-Nagel following the company’s manual.
For the storage of positive plasmid constructs a midi prep with the NucleoBond®
Xtra Midi kit was performed. With this method a higher yield of plasmid DNA can
be achieved. 50 to 100 ml LB medium with appropriate antibiotics was inoculated
with a E. coli XL-2 blue colony derived from a transformation with positive plasmid
DNA. The culture was incubated overnight at 37 ◦C, harvested and then the company’s
manual was followed to purify the plasmid.
2.3.8. DNA sequencing
For the verification of cloned DNA sequences the plasmids were sent to Eurofins
MWG Operon in Ebersberg. Following the suggested sample preparation, 15 µl of
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50-100 ng/µl of plasmid DNA was mixed with 2 µl of primer with a concentration of
10 pmol/µl. The results were checked with the alignment program BioEdit (Hall,
1999).
2.4. Transformation and cultivation of Escherichia
coli
2.4.1. Transformation via heatshock
Chemically competent E. coli cells were either incubated with a finished ligation re-
action or 0.5 to 2 µg of plasmid DNA. The reaction sample was incubated on ice for
30 min and then a heat shock of 30 sec at 42 ◦C was applied (Cohen and Chang, 1973).
The sample was immediately put back one ice for a further 5 min before spreading it
on a LB plate with the appropriate antibiotics. The plate was then incubated at 37 ◦C
overnight.
2.4.2. Cultivation media
E. coli was cultivated in Luria-Bertani-Medium (LB) (Bertani, 1951) which is described






2.4.3. Synthesis of selenomethionine-containing proteins
To obtain selenomethionine-labelled protein (Hendrickson et al., 1990) the plasmid had
to be transformed into a methionine auxotroph strain like E. coli 834 (DE3) (Novagen,
Darmstadt, D). Then, a colony was inoculated in 10 ml LB broth containing the rele-
vant antibiotics at 37 ◦C overnight. The cells were harvested and washed three times
with 10 ml sterile water to wash out any remaining LB substances. The final pellet
was re-suspended in 1 ml sterile water and inoculated in 1 L pre-warmed SelenoMet
medium (AthenaES, Baltimore, MD-US) supplemented with 50 µg/ml selenomethio-
nine (Sigma-Aldrich). Cells were grown at 30 ◦C overnight before the addition of
IPTG to a final concentration of 0.5 mM and growth was continued for a further 6 h
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prior to harvest (40 min, 6,000 g). Protein purification was carried out following the
same protocol as used for the native protein (see section 2.6).
2.5. Protein expression test
Protein expression tests were conducted to check whether the chosen expression tem-
perature, the concentration of IPTG, and if required additives like ethanol were suf-
ficient to produce the target protein in the folded state in the supernatant. Usually,
expression was first tested at 37 ◦C and if necessary down to 20 ◦C. In the case of E.
coli ArcticExpress, expression was tested at 12 ◦C.
50 ml LB with the required antibiotics was inoculated with an overnight preculture at
1:50 dilution and grown at 37 ◦C, shaking (120 - 180 rpm) until an OD600 of 0.5 to
0.8 was reached. Prior to the addition of IPTG, 5 ml of the culture were removed and
centrifuged at 6,000 g for 15 min. The pellet was frozen at -20 ◦C. IPTG was added
at a final concentration of 0.1 to 1 mM. After that, 5 ml-samples were taken at certain
time points (usually before IPTG, and 1, 3, 5, and 16 hours after IPTG induction),
centrifuged and frozen as well.
To extract the protein, the collected samples were thawed on ice. Then 200 µl lysis
buffer (see table 2.4) were added to each sample, transferred into a 1.5 ml Eppendorf
tube and sonicated thrice for 10 sec at 20% on ice with at least a 30 sec break be-
tween each sonication step. Subsequently, the samples were centrifuged for 30 min at
16,000 g and 4 ◦C. The supernatant was transferred into a new E-cup and 6× SDS
buffer (see table A.2) was added to both the supernatant and the pellet. Between 2 to
5 µl of sample together with a protein marker (Bench-MarkTM Ladder Invitrogen)
were applied on a SDS-PAGE gel (see appendix A.1), run at 40 mA for 40 min and
then stained with Coomassie blue (see appendix A.3).
2.6. Protein purification
1 L of LB broth containing the appropriate antibiotics was inoculated with an overnight
preculture at 1:50 dilution and allowed to grow at 37 ◦C until an OD600 of 0.5 - 0.8
was reached. Then, protein expression was induced by adding IPTG to a certain,
previously tested final concentration. Cells were usually grown overnight, harvested by
centrifugation at 6,000 g for 15 min at 4 ◦C and the resulting cell pellets were stored
at -20 ◦C for further experiments.
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The following protocol was the standard procedure for every newly tested protein.
If the standard buffers proved to be unsuitable for the protein different buffers were
tested. These changes are mentioned in the results chapter (see chapter 3).
Sonication of pellets
Previously frozen pellets were thawed on ice, re-suspended in ice-cold lysis buffer (see
table 2.4, 15 ml buffer per 4 g pellet) and disrupted on ice by sonication. A spatula tip
of DNase (MP Biomedical) was added to the lysate and then centrifuged at 37,000 g
for 40 min at 4 ◦C to remove cellular debris.
Protein purification over Ni-NTA-column
Beforehand, a column containing Ni-NTA superflow resin (Qiagen, Hilden, D) to
which proteins with His-tags can bind was pre-equilibrated with buffer A (see table
2.4). The supernatant was sterile filtered through a 0.22 µm syringe filter (Roth)
then it was applied onto the column. The column was washed with 8 column volumes
(cv) of buffer A. Then 10 cv of buffer B followed by 8 cv of buffer A containing 40 mM
imidazole (pH 7.3) were applied to remove non-specifically bound proteins from the
column. Finally, the protein complex was eluted over 5-7 cv using a linear gradient of
40-500 mM imidazole in buffer A in 1 ml fractions. Fractions from the peak area of
the chromatogram were checked on SDS-PAGE gels.
Dialysis
Fractions containing the target protein were pooled, transferred into a dialysis mem-
brane (MWCO 8-10 kDa, 25 mm) (Roth), and dialysed against 2 L buffer C (see
table 2.4) at 4 ◦C overnight.
Size exclusion chromatography
After concentrating the protein with a Vivaspin concentrator (GE Healthcare) ap-
propriate for the size of the protein, the protein was further purified by size-exclusion
chromatography on a HiLoad 16/60 Superdex 200 column (GE Healthcare) equili-
brated and run with buffer C. The protein purity was checked by SDS-PAGE and then
concentrated to 7-10 mg/ml with a Vivaspin concentrator. The protein concentration
was determined with the Bradford assay (see appendix A.3).
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Table 2.4.: Buffers for protein purification
Lysis buffer






50 mM Hepes pH 7.3
30 mM KAc
Buffer B
50 mM Hepes pH 7.3
300 mM KAc
Buffer C






2.7. TEV-cleavage to remove His-tag
To remove the N-terminal His-tag from the protein the TEV cleavage-site was used.
After size exclusion chromatography, the peak fraction was pooled and transferred into
a 15 ml Falcon tube. Then, the protein concentration was measured with a Bradford
assay. 2 µg TEV protease per 100 µg protein were added and incubated on a shaker at
room temperature overnight. A second size exclusion chromatography was performed
to remove the TEV protease from the protein.
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2.8. Crystallization approach
Before the start of crystallization trials, the PCTM Pre-Crystallization Test (Hampton
Research, Aliso Viejo, CA-US) was used to identify the optimal protein amount for
crystallization. The protocol as described by the company was followed (Watson and
O’Callaghan (2005)).
Crystallization trials were performed with various sparse-matrix screens using the sit-
ting drop vapour diffusion method. Drops were set up in 96-well plates (Greiner Bio
One GmbH, Frickenhausen, D) by automatically mixing (mosquito Crystal, TTP
Labtech Ltd., Hertfordshire, UK) 200 nl each of the protein and the reservoir so-
lution, which were equilibrated against 100 µl reservoir solution. Plates were kept at
20 ◦C, unless otherwise stated. Plates were frequently inspected for crystal growth
with a light microscope (Olympus SZX12, Hamburg, D) and a polarizing filter.
When initial crystals were found a grid screen was conducted to find the optimal crys-
tallization condition. This means that always only one of the crystallization ingredients
of the original condition was altered. For example, the pH of the buffer was changed in
both directions (more acidic or more alkaline) or a different buffer was used altogether.
The amount of salts or precipitant was varied as well while the other crystallization
components remained unchanged. This method was conducted in 96-well as well as
24-well plates (Greiner Bio One GmbH).
2.8.1. Crystal seeding
To enhance crystal growth seeding solutions made up of small crystals or quasicrystals
were prepared and used during crystal drop set up. These small crystal fragments in
the solution act as nuclei to which protein molecules can attach to form bigger crystals.
Crystals were broken up with a small glass probe (courtesy of Douglas Instru-
ments), and transferred into a 1.5 ml E-cup containing 50 µl of the reservoir solu-
tion and a seed bead (Hampton Research). The crystal solution was vortexed for
two minutes, stopping every 30 sec to cool it on ice. Then, several dilutions were pre-
pared and immediately frozen at -20 ◦C. Usually a 1:100 or 1:1000 seeding solution was
used for setting up drops in a 1:3:4 (seeding solution:reservoir solution:protein) ratio.
2.8.2. Additive screening
A small amount of an additive was added to an already established crystallization con-
dition. It causes a slight change in the crystallization condition and hence might cause
the formation of better diffracting crystals.
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Commercial additive screens containing salts, co-factors, amino acids etc. are avail-
able, but any spare matrix screen can be used as additive, as well. To do so, the
favoured crystallization condition was transferred into the reservoir well of a 96-well
plate. With the mosquito Crystal 200 nl protein were mixed with 180 nl of the reservoir
solution. Then, 20 nl each of one of the 96 crystal conditions of the Crystal Screen 1/2
(Hampton Research) was mixed with the protein-reservoir solution and treated as
mentioned above in section 2.8.
2.9. Crystal measurement
Prior to data collection, crystals were harvested from the drops using mounted cryo-
loops (Hampton Research), briefly transferred to a cryoprotection buffer consisting
of mother liquor supplemented with a cryoprotectant like PEG 400, and subsequently
flash-cooled and stored in liquid nitrogen. The crystals were measured at beamline
X10SA (Swiss Light Source, Paul Scherrer Institute, Villigen, CH) or at beamline
P11 (Deutsches Elektronen-Synchrotron, PETRA III, Hamburg, D) under a constant
stream of liquid nitrogen. Both beamlines feature a Pilatus detector (Dectris Ltd.,
Baden, CH) that enabled rapid data collection.
A multi-wavelength anomalous diffraction (MAD) measurement was conducted to de-
termine the phases. Firstly, a fluorescence scan of a selenomethionine (SeMet) deriva-
tive crystal was performed to determine the absorption peak as well as the point of
inflection and remote of the absorption curve of Se (Hendrickson et al., 1990). Then,
three datasets were recorded at three different wavelengths.
2.10. Structure determination
2.10.1. Processing the datasets
All datasets recorded at the beamline were processed with the XDS program suite
(Kabsch, 2010). In the case of MAD data it was necessary to unset the parameter
FRIEDEL’S LAW because of anomalous scattering effects. At first, reflections were
indexed and integrated, possible space groups were determined and statistics about the
dataset were calculated. One output file of XDS, CORRECT.LP, gave statistics about
the quality of the data and helped to determine a reasonable resolution cut-off. With
XSCALE several datasets can be scaled relative to each other, which was used for the
MAD datasets. To prepare the data for further use, they were converted in a suitable
format using XDSCONV.
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2.10.2. Phase determination
The phases were determined from a derivative dataset with the program suite SHELX
(Sheldrick, 2010). At first, a name.hkl file was produced with XDSCONV. Then,
XPREP (Bruker) was used to prepare the file for SHELXD/E by writing out several
output files. The instruction file (name fa.ins) and the anomalous data in name fa.hkl
were used by SHELXD to locate the heavy atoms (Se) and to calculate the phases of the
heavy atom substructure. It also provided an output file containing the marker atom
coordinates (name fa.res). SHELXE calculated the phases of the protein using this
file, the anomalous and native data (name.hkl, calculated in XPREP). The resulting
electron density map name.phs was visualized in Coot.
2.10.3. Computing a starting model with ACMI
For the automated construction of a structure model the program suite ACMI (Auto-
matic Crystallographic Map Interpretation) was used because it is specially designed
for low-resolution maps (DiMaio et al., 2007). The program is command line based
and consists of three consecutive steps to calculate a model (see documentation ACMI ).
At first, the electron density map (in name.map-format), the protein sequence (name.seq),
and the crystal parameters (name.cryst) were given to SHFEAR. It searched the elec-
tron density map for a set of templates (5-mer) for each amino-acid in the protein
sequence and calculated the probability distribution for each amino-acid at every loca-
tion. The resulting files were used by the next program, BP. It refined the probabilities
calculated by SHFEAR by computing the probability distribution of each amino-acid
at every location in the map by taking the location of the other amino-acids into ac-
count as well. It calculated maps and a backbone model consisting of Cα-atoms only.
In the final step, SIDECHAIN PF used the information computed before to calculate
a set of models that best explained the electron density map. Using the argument -b,
20 models were generated.
2.11. Chemical cross-linking with BS3
Chemical cross-linking provides a permanent link between proteins and can give infor-
mation about the location of binding using mass spectrometry analysis following in-gel
digestion (Rappsilber et al., 2000).
70 pmol of the purified protein complex DCTN1412-533-IC2-69 was incubated with 125 µM
and 250 µM of the lysine specific crosslinker BS3 (Thermo Scientific) for 30 min at room
temperature. Each cross-link experiment was performed four times to yield enough
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cross-linked protein for mass spectrometry. The reaction was stopped by adding SDS
sample buffer; the protein bands were separated on a 17.5% SDS-PAGE and stained
with Coomassie blue. The appropriate bands were cut from the gel with a clean scalpel,
cut into small pieces, and placed into a 1.5 ml Eppendorf tube. All four excised pro-
tein bands prepared with the same BS3 concentration were pooled into one Eppendorf
tube. The gel pieces were washed twice with each 150 µl 50 mM ammonium bicar-
bonate (ABC) and 150 µl 50 mM acetonitrile (ACN) to remove Coomassie. For the
digestion, the gel pieces containing the cross-linked proteins were covered with trypsin
(13 ng/µl in 10 mM ABC and 10% ACN) and incubated overnight at 37 ◦C.
Next day, the supernatant was removed from the gel pieces and collected in a new
1.5 ml Eppendorf tube. Then, the proteins were extracted from the gel pieces in three
steps. First, the gel slices were incubated with water (10 µl/slice) followed by ACN
(80 µl/slice). Then, the gel pieces were incubated with 5% acetic acid (65 µl/slice)
followed by ACN (50 µl/slice). This was followed by a final step of ACN (40 µl/slice).
The respective supernatants were collected after every step. Each added solution was
incubated for 15 min at 37 ◦C, at 1050 rpm in the dark. The total supernatant was
concentrated to 6 µl in speed vac. An equal amount of a 10% ACN and 0.2% formic
acid solution was added to the sample, which was then subjected to mass spectrometry
(LTQ Orbitrap Velos, Thermo Scientific).




3.1. Cloning and protein purification of various
dynein-dynactin constructs
Several DCTN1-IC constructs were cloned based on studies by Siglin et al. (2013) and
Morgan et al. (2011) to address the question of dynein-dynactin interaction. Figure
3.1 contains an overview of the various constructs. The DCTN1-fragment length was
kept in all plasmids while the length of IC changed. In all plasmids, except pMK243,
DCTN1412-533 contained an N-terminal His-tag for the purification with an Ni-NTA
column.
DCTN1 N C









Figure 3.1.: Overview of all DCTN1-IC constructs. All constructs contain
DCTN1412-533. The length of the N-terminal IC fragment, however, changes
in the various constructs. In contrast to the other plasmids, pMK243 has the
N-terminal His-tag attached to IC and not DCTN1.
3.1.1. DCTN1412-533-IC2-47
For the first construct (pMK220) the DCTN1 and IC fragment sizes were based on
the study by Siglin (2010). Both fragments were cloned into the expression vector
pRSFmD1mako (see figure B.1), which allowed a simultaneous expression of the pro-
teins. The plasmid contains two multiple cloning sites (MCS) each having an N-
terminal 6× His-tag for the purification with a Ni-NTA column. Human IC2-47 was
amplified with primers PF7 and PF8b using plasmid pMK186 as template. Likewise,
chicken DCTN1412-533 was amplified with plasmid pMK146b as template and primers
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PF9 and PF10b. IC2-47 and DCTN1412-533 were ligated into the multiple cloning sites
through the restriction sites NcoI/ HindIII (MCS1) and MluI/ BsrGI (MCS2), re-
spectively. The use of NcoI for IC2-47 resulted in the removal of the His-tag for this
protein fragment whereas the choice of restriction enzymes for DCTN1412-533 generated
an N-terminal His-tag. The cloning steps were carried out in E. coli XL-2 blue. After a
positive clone was determined, the plasmid was transformed into the expression strain
E. coli BL21-CodonPlus(DE3)RIL. An expression test in LB-medium supplemented
with kanamycin (25 µg/µl) and chloramphenicol (34 µg/µl) and induced with 0.1 mM
IPTG (end-concentration) demonstrated that the protein complex was already soluble
at 37 ◦C (see figure 3.2). However, usually the protein was expressed at 30 ◦C to avoid
an overgrowth of the E. coli culture.
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Figure 3.2.: DCTN1412-533-IC2-47 expression test at 37
◦C. M = Protein marker,
P = Pellet, S = Supernatant; Samples were taken before IPTG induction and
after 1, 2, 3, 4, 5, and 20 hours. Pellet and supernatant of each sample were
applied on a 17.5% SDS PAGE gel.
The purification of the protein complex was carried out with a Ni-NTA column fol-
lowed by size-exclusion chromatography as described in section 2.6 (see figure 3.3).
Further experiments revealed, that adding 5% glycerol to buffer C for the dialysis and
gelfiltration produced a more stable protein complex. This was apparent in SDS gels
where the lower IC protein band was more pronounced. However, IC always produced
a fainter protein band than DCTN1.
In an attempt to enrich IC2-47 the His-tag between IC and DCTN1 was swapped
(pMK243). Firstly, a PCR with primers PF9-ohneHis and PF10b and plasmid pMK146b
as template was conducted to amplify DCTN1412-533. The PCR product was ligated
into vector pRSFmD1mako over the restriction sites MluI and NdeI, which resulted
in a His-tag free DCTN1412-533. Then, His-IC2-47 was amplified with PF7-HisTev and
PF8b and pMK186 as template. The resulting PCR product contained a 8× His-tag
28
3.1. Cloning and protein purification of various dynein-dynactin constructs















Figure 3.3.: SDS-PAGE gels of DCTN1412-533-IC2-47 purification. (Left) 17.5%
SDS-PAGE gel after Ni-NTA purification. Ft = flowthrough, W1 = first
washing step with buffer A1 and A2, W2 = second washing step with buffer
A1 supplemented with 40 mM imidazole (Right) 17.5% gel after gelfiltration.
Above the gels the fraction numbers are given and on the left the size of the
respective protein marker lanes.
and was also cloned into the pRSFmD1mako vector already containing DCTN1412-533.
Verification of the cloned PCR products was carried out with restriction digestion.
A positive plasmid was transformed into E. coli BL21-CodonPlus(DE3)RIL and then
protein purification was performed (see figure 3.4) as described for plasmid pMK220.
In contrast to DCTN1412-533-IC2-47 , gelfiltration resulted in three distinct peaks; frac-
tions 66-76, 86-97 and 103-113. The first two peak fractions were pooled separately
and dialysed against buffer C. Half the volume of the first peak was then concentrated
to 6.8 mg/ml for crystallization trials. The other half was mixed together with the
second peak fractions and the His-tag was cleaved from IC2-47 as described in section
2.7 because of the potential interference of the tag with the protein interaction. This
was followed by a second gelfiltration to remove TEV protease from the sample. Again,
three peaks were visible in the chromatogram, which were made up of fractions 64-74,
99-109, and 115-120. Only fractions 66-74 were pooled and concentrated to 7 mg/ml
with a Vivaspin MWCO 5000 since it was the only peak containing both proteins.
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M  Ft W1 W2 11  12  14  17  20  24  26  27  40 M  66  67 70  73  74 75  86  87  92 95 96 97 108 115
























Figure 3.4.: SDS-PAGE gels of DCTN1412-533/His-TEV-IC2-47 purification.
(Left) 17.5% SDS gel after Ni-NTA purification. Ft = flowthrough, W1 =
first washing step with buffer A1 and A2, W2 = second washing step with
buffer A1 supplemented with 40 mM imidazole (Right) 17.5% gel after first
gelfiltration. (Bottom) 17.5% SDS gel from second gelfiltration after TEV-
cleavage. Above the gels the fraction numbers are given and on the left the
size of the respective protein marker lanes.
3.1.2. DCTN1412-533-IC2-84
Morgan et al. (2011) demonstrated with an NMR titration experiment using recom-
binantly expressed Drosophila melanogaster proteins that two regions of IC bind to
DCTN1. Transferring this finding onto human IC (see figure 3.5) resulted in a longer
IC fragment (IC2-84) in the new construct (pMK242).
Initially, the longer IC fragment was amplified with primers PF7 and PF8-2 using
pMK186 as template. The shorter IC fragment in pMK220 was cut out using the
former ligation sites NcoI/HindIII. The new IC2-84 was then cloned into the vector
over the same restriction sites. The solubility of the protein complex was verified in
E. coli BL21-CodonPlus(DE3)RIL with an expression test at 37 ◦C as described in
3.1.1. This was followed by the first purification step over a Ni-NTA column. Fraction
inspection on SDS-PAGE gel showed highly degraded protein bands for both DCTN1
and IC (data not shown). The purification protocol was modified to improve protein
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Figure 3.5.: Alignment of dynein intermediate chains. Dm = Drosophila
melanogaster, Hs = Homo sapiens; The alignment of the N-terminal part
of D. melanogaster and human dynein intermediate chain is shown. The grey
bars represent the two binding regions found in D. melanogaster by Morgan
et al. (2011). The blue bars depict the length of the various IC constructs
designed in this work.
stability mainly by changing the pH of the buffers from 7.3 to 8.0. For the lysis of
cells the buffer was changed to 25 mM Hepes (pH 8.0), 200 mM NaCl, and 20 mM
imidazole (pH 8.0) (for reference of standard buffer see section 2.4). After the sample
was applied onto the column, it was washed with 20 column volumes buffer A1 (25 mM
Hepes (pH 8.0), 200 mM NaCl, and 20 mM imidazole (pH 8.0)), followed by 20 column
volumes buffer A1 supplemented with 40 mM imidazole (pH 8.0), and finally eluted
using a linear gradient of 60 to 500 mM imidazole over 6-8 column volumes. The peak
fractions were visualised on SDS gel (17.5%) (see figure 3.6), pooled and dialysed in
buffer C to remove imidazole. Again, the buffer (see section 2.4 for composition) was
altered to stabilize the protein by adding 25 mM Hepes (pH 8.0) and 150 mM NaCl
instead of 20 mM Hepes (pH 7.3) and 100 mM NaCl, and by supplementing with 5%
glycerol. Despite the change of buffer the DCTN1412-533-IC2-84 complex still proved to
be quite unstable and precipitated within 16 hours after being concentrated with a
Vivaspin MWCO 5000 to 8-10 mg/ml. This meant that crystallization trials had to be
set up right away. Furthermore, the expression level of this construct was considerably
lower in comparison to the other constructs.
31
3. Results
















M  36  38  40  42 44  45  46  48  50  52  56  60  62  66  kDa
Figure 3.6.: SDS-PAGE gels of DCTN1412-533-IC2-84 purification. (Left) 17.5%
SDS-PAGE gel after Ni-NTA purification. Ft = flowthrough, W1 = first wash-
ing step with buffer A1, W2 = second washing step with buffer A1 supple-
mented with 40 mM imidazole; Fractions 14 to 54 were pooled for further use.
(Right) 17.5% gel after gelfiltration. Above the gels the fraction numbers are
given and on the left the size of the respective protein marker lanes.
3.1.3. DCTN1412-533-IC2-69
The fast precipitation of DCTN1412-533-IC2-84 led to the consideration that the ex-
tension from 47 aa to 84 aa might have been too long. A construct was designed
(pMK248) that terminated before the stretch with several prolines (for more details
see discussion 4.1). IC2-69 was amplified with primers PF7 and PF8-3 and pMK186
as template. The plasmid pMK220 was digested with NcoI/HindIII to remove IC2-47
and to ligate the newly amplified IC fragment into the plasmid. After transforming a
positive plasmid into E. coli BL21-CodonPlus(DE3)RIL a protein expression test at
37 ◦C demonstrated that the protein complex was soluble. Protein purification was
carried out in the exact same manner as for DCTN1412-533-IC2-47 and the purified com-
plex showed a similar stability (see figure 3.7). The protein complex was concentrated
with a Vivapsin MWCO 5000 to 7-10 mg/ml.
32
3.2. Crystallization of the various DCTN1-IC constructs and data collection

















Figure 3.7.: SDS-PAGE gels of DCTN1412-533-IC2-69 purification. (Left) 17.5%
SDS-PAGE gel after Ni-NTA purification. Ft = flowthrough, W1 = first
washing step with buffer A1 and A2, W2 = second washing step with buffer
A1 supplemented with 40 mM imidazole (Right) 17.5% SDS-PAGE gel after
gelfiltration. Above the gels the fraction numbers are given and on the left
the size of the respective protein marker lanes in kDa.
3.2. Crystallization of the various DCTN1-IC
constructs and data collection
In general the initial search for crystallization conditions was performed with the sit-
ting drop method in 96-well plates using various sparse matrix screens (Wizard I-IV,
Crystal Screen 1+2, Protein Complex Suite, Morpheus, JCSG Core II). 100 µl of a
crystallization condition was pipetted into the reservoir well using a pipetting robot
(Tecan). Protein and reservoir solution were mixed in a ratio of 1:1 (200 nl each).
Plates were kept at 20 ◦C and frequently checked for crystals.
3.2.1. Crystallization of DCTN1412-533-IC2-47 construct
Initial screening was performed by Christian Eckert. 4 mg/ml were used for screening
in 96-well plates. Tiny spherulites were found in condition 16 (0.2 M sodium chlo-
ride, 0.1 M MES pH 6.5, 10% PEG 4000) of the Protein Complex Suite (Quiagen).
This was followed by different grid screens in 24-well plates using the hanging drop
method in which various buffers, salts and PEG concentrations were tested. There,
two crystallization conditions were found that yielded two different crystal forms after
3-5 days, house-like (5% PEG 8000, Hepes pH 7.5) and trapezium-like crystals (11%
PEG 1000, 150 mM ammonium sulphate, 0.1 M Tris pH 8.5), which can be seen in
figure 3.8 A. Both crystal forms were frozen in different cryoprotectants and measured
at beamline PXII at the Swiss lightsource in Villigen (CH). The best crystal belonging
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to the house-like form diffracted up to 6 Å. The trapezium-like crystals displayed even
lower diffraction qualities. Following this finding, further grid screens were performed
using 10 mg/ml protein. This resulted in a crystallization condition (6% PEG 4000,
300 mM ammonium sulphate, 0.1 M Na-citrate pH 5.5, 5% glycerol) in which bigger
house-like crystals with edge lengths of 100-200 µm (see figure 3.8 B) appeared after
3-5 days. Initially, the best crystal contained 15% PEG 400 as cryoprotectant and
diffracted to a resolution of 3.5 Å.
Much later native crystals grew in 0.1 M Na-citrate pH 5.5, 5% PEG 4000, and 0.1 M
ammonium sulphate. As cryoprotectant 15% glycerol was added to the crystal con-
dition and measurements were conducted at beamline P11 at PETRA III, Hamburg.
The best crystal diffracted to 2.9 Å.
11% PEG 1000, 150 mM ammonium 
sulfate, 0.1 M Tris pH 8.5
5% PEG 8000, 0.1 M Hepes  pH 7.5
6% PEG 4000, 300 mM ammonium sulfate, 0.1 M
Na-citrat pH 5.5, 5% glycerol
A
B C
5% PEG 4000, 300 mM ammonium sulfate, 0.1 M
Na-citrat pH 5.5, 5% glycerol + 10% Additive
Figure 3.8.: Crystals of DCTN1412-533-IC2-47 (A) These are the first crystals which
formed in the initial grid screen. The crystals in the left image display a
trapezium form whereas crystals on the right were denoted as house-like. (B)
This image shows the house-like crystal form in the final crystal condition.
(C) The crystals found in the additive screening showed an elongated version
of the house-like form. However, this did not affect resolution.
In search of better diffracting crystals several strategies were followed. For example,
an additive screening was performed as described in subsection 2.8.2. 10% of Crystal
Screen 1+2 (Hampton Research) and Wizard 1+2 (Emerald BioStructures)
were added to the protein-reservoir (6% PEG 4000, 300 mM ammonium sulphate, 0.1 M
Na-citrate pH 5.5, 5% glycerol) drops. After one day the first small crystals appeared
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in a drop with condition 48 from Crystal Screen 2 (10% PEG 20,000, 0.1 M bicine (pH
9) and 2% dioxane) as additive. They looked like an elongated version of the house-like
form. In 24-well plates grid screens were set up to scan for better crystallization con-
ditions. The reservoir composition as well as the amount of condition 48 were varied
and resulted in bigger elongated crystals as shown in figure 3.8 C. Measurements at
beamline PXII at the SLS (Villigen, CH) showed that none of the elongated crystals
diffracted better than 3.5 Å.
Another strategy was to change the buffer (Na-citrate) while the rest of the original
crystallization condition was kept. Buffers imidazole (pH 5.4), Bis-Tris (pH 5.6) and
Na-acetate (pH 5.4) were chosen for this purpose. No crystals appeared in drops set
up with Bis-Tris but the other two buffers produced crystals similar to the house-like
form. However, x-ray measurement at the SLS showed no improvement in resolution.
Furthermore, crystallization trials were set up with protein concentrated after dialysis
and leaving out gelfiltration to have more IC2-47 bound to DCTN1412-533. A first set up
using the sparse matrix screen Protein Complex Suite and seeding with DCTN1412-533-
IC2-47 -seed revealed crystals in several conditions with pHs between 7 and 8. Grid
screens with 0.1 M Hepes pH 7.3 or Tris pH 8 were prepared in 24-well plates. Crystals
appeared in conditions containing 0.1 M Hepes pH 7.3, 0.1 M magnesium acetate and
2-7% PEG 8000 after 3-5 days. They formed the same house-like crystals. Subse-
quently, crystals were frozen in their mother liquor containing 20% glycerol and then
measured at beamline P11 at PETRA III, Hamburg. The best crystal diffracted up to
3.4 Å.
Crystallization with DCTN1412-533-IC2-47 -His-Tev was split in two parts. On the one
hand, protein from the first gelfiltration (7 mg/ml) and on the other hand, protein with
the His-tag cleaved of IC2-47 (10 mg/ml) were applied to various crystal screens. In
both cases, crystallization was facilitated by adding crystal-seed (see subsection 2.8.1)
derived from DCTN1412-533-IC2-47 crystals to the protein-reservoir drop. The 96-well
plates were checked frequently for crystals. After 4 months crystals were found in sev-
eral crystallization conditions (see figure 3.9) in the set up with the His-tag-containing
protein complex. The conditions in which crystals appeared differ in their buffers and
their pH but all contain high amounts of long-chained PEGs (Protein Complex Suite
→ 29: 0.1 M Tris pH 8.0, 20% PEG 4000; 36: 0.2 M Potassium iodide, 0.1 M MES pH
6.5, 25% PEG 4000; 61: 0.1 M Hepes pH 7.0, 20% PEG 8000). Because the crystals
were grown together on the base they were separated before being frozen in mother
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liquor containing 15% glycerol. This was followed by measurements at beamline P11
at PETRA III in Hamburg. Diffraction was no better than 20 Å.
Figure 3.9.: Crystals from DCTN1412-533-IC2-47 -His-Tev These crystals all grew
in conditions from Protein Complex Suite. They all formed elongated crystals
which were grown together on the base. (Left) These crystals grew in 0.1 M
Tris pH 8.0 and 20% PEG 4000. (Center) This crystal condition contains
0.2 M Potassium iodide, 0.1 M MES pH 6.5, and 25% PEG 4000. (Right)
The last crystal was found in 0.1 M Hepes pH 7.0, and 20% PEG 8000.
3.2.2. Crystallization of DCTN1412-533-IC2-47 with
incorporated selenomethionine
In order to solve the phase problem protein with incorporated selenomethionine in-
stead of the usual methionine was produced. Each DCTN1412-533 fragment contains 4
methionine positions and IC2-47 features one position in which selenomethionine could
be incorporated. As a rule of thumb 1 selenomethionine per 100 amino acids is suffi-
cient for conducting multi-wavelength anomalous diffraction measurements (Hendrick-
son and Ogata, 1997). Protein expression and purification were carried out as described
in subsection 2.4.3. The protein complex was concentrated with a Vivaspin 5000 to
8 mg/ml and crystallization trials were set up in 24-well plates using the native crys-
tallization condition as a starting point for grid screens. Crystals formed in 5% PEG
4000, 150 mM ammonium sulphate, 0.1 M Na-citrate pH 5.5, and 5% glycerol and they
looked like the crystals derived from native protein (see figure 3.8 B). For x-ray mea-
surements crystals were shortly soaked in a cryoprotectant (mother liquor + 15% PEG
400) and frozen in liquid nitrogen. The derivative crystals were measured at beamline
PXII at the SLS in Villigen (CH) and the best crystal diffracted to 3.4 Å.
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3.2.3. Crystallization of DCTN1412-533-IC2-84 construct
Fresh protein (8 mg/ml) was used to set up crystallization trials in 96-well plates using
various sparse matrix screens (Wizard 1+2, Protein Complex Suite, Crystal Screen
1+2, Morpheus, JCSG Core II). Plates were checked regularly but crystals or crystal-
like structures did not form.
3.2.4. Crystallization of DCTN1412-533-IC2-69 construct
Crystallization was carried out with concentrated protein after dialysis (9 mg/ml) and
after gelfiltration (8 mg/ml). Various sparse matrix screens were applied. Crystals
were found only in a set up with protein used after dialysis (Wizard 3+4 → 52: 0.2 M
ammonium sulphate, 0.1 M BisTris pH 5.5). The shape of these crystals was the same
as found in DCTN1412-533-IC2-47 (see figure 3.8 C). After freezing the crystals in their
mother liquor supplemented with 15% PEG 400, the crystals were measured at beam-
line P11 at PETRA III (Hamburg). They showed reflections up to 6 Å. Furthermore,
dissolving some of the crystals in water and running the sample on 17.5% SDS gel only
showed a protein band for DCTN1412-533 and not IC.
3.3. Data processing
Data processing was performed with XDS (Kabsch, 2010) to reduce data and to deter-
mine cell parameters and the space group (see subsection 2.10.1). Native and derivative
protein crystallized in the primitive tetragonal space group P41212. The determination
of the exact space group resulted from the examination of systematic absences of re-
flections. The absence of reflections for 00l:l = 4n+1, 4n+2, and 4n+3 and for h00:h =
2n+1 led to the conclusion that the crystals either belonged to space group P43212 or
P41212. Since those two space groups are enantiomer to each other only the successful
solution of the phase did help to determine P41212 as the true space group.
The best measured derivative DCTN1412-533-IC2-47 dataset diffracted until 3.4 Å and
had the following cell parameters: a = b = 156.34 Å, c = 131.14 Å, α = β = γ =
90°. The dataset consisted of 360 diffraction images taken at an oscillation range of
0.5°. 262,952 reflections were observed of which 42,432 reflections were unique. This
equates to a multiplicity of 6.2. In the highest resolution shell (3.6-3.4 Å) it exhibited




 SUBSET OF INTENSITY DATA WITH SIGNAL/NOISE >= -3.0 AS FUNCTION OF RESOLUTION
 RESOLUTION     NUMBER OF REFLECTIONS    COMPLETENESS R-FACTOR  R-FACTOR COMPARED I/SIGMA   R-meas  Rmrgd-F  Anomal  SigAno   Nano
   LIMIT     OBSERVED  UNIQUE  POSSIBLE     OF DATA   observed  expected                                      Corr
    10.02        9999    1659      1672       99.2%       4.1%      4.1%     9998   32.80     4.5%     2.6%    89%   3.596     659
     7.16       18641    2914      2914      100.0%       6.9%      6.7%    18641   20.99     7.6%     4.9%    73%   2.264    1284
     5.86       22827    3752      3752      100.0%      18.1%     18.9%    22823    8.53    19.9%    15.7%    54%   1.396    1699
     5.09       27887    4421      4421      100.0%      22.0%     22.2%    27886    7.41    24.0%    19.5%    34%   1.118    2035
     4.55       32191    5008      5008      100.0%      15.2%     14.2%    32190   10.57    16.5%    14.4%    32%   1.159    2328
     4.16       33916    5544      5544      100.0%      22.0%     21.3%    33912    7.92    24.1%    19.3%    19%   1.000    2592
     3.85       36683    6014      6015      100.0%      29.1%     28.6%    36679    6.25    31.8%    25.5%    17%   0.949    2830
     3.61       41202    6468      6468      100.0%      57.7%     60.2%    41201    3.27    62.9%    50.8%     3%   0.778    3055
     3.40       39607    6652      6879       96.7%      92.9%    100.8%    39525    1.87   101.9%    90.5%     4%   0.747    3079
    total      262953   42432     42673       99.4%      19.0%     19.1%   262855    8.21    20.8%    23.7%    38%   1.154   19561
Figure 3.10.: Processing statistics of derivative DCTN1412-533-IC2-47 Excerpt
was taken from CORRECT.LP.
The best native crystal derived from the DCTN1412-533-IC2-47 construct and formed in
0.1 M Na-citrate pH 5.5, 5% PEG 4000, 0.1 M ammonium sulphate with a protein-
to-reservoir solution ratio of 1:2. It had a resolution of 2.9 Å and displayed slightly
different cell parameters (a = b = 155.32 Å, c = 129.26 Å, α = β = γ = 90°). The
processed dataset consisted of 1800 images taken at an oscillation range of 0.5°. The
935,917 observed reflections, which contained 35,585 unique reflections, equated to a
multiplicity of 26.3. A signal-to-noise ratio of 1.78 and a CC1/2 of 73.4% could be found
in the highest resolution shell (2.95-2.9 Å) (see figure 3.11).
RESOLUTION     NUMBER OF REFLECTIONS    COMPLETENESS R-FACTOR  R-FACTOR COMPARED I/SIGMA   R-meas  CC(1/2)  Anomal  SigAno   Nano
   LIMIT     OBSERVED  UNIQUE  POSSIBLE     OF DATA   observed  expected                                      Corr
    40.00         130      10        11       90.9%       2.8%      3.3%      129   79.07     2.9%   100.0*   -12    0.828       2
    30.00         497      27        27      100.0%       3.0%      3.4%      497   94.95     3.1%   100.0*    71    1.171      10
    20.00        1990      94        94      100.0%       2.4%      3.4%     1990   92.69     2.4%   100.0*   -46    0.670      48
    10.00       18593     848       848      100.0%       2.6%      3.4%    18593   94.68     2.6%   100.0*    -5    0.657     585
     6.00       79844    3284      3286       99.9%       3.8%      4.1%    79844   65.21     3.9%   100.0*    -6    0.795    2648
     4.00      252804    9604      9605      100.0%       7.6%      7.5%   252804   42.67     7.8%   100.0*    -8    0.754    8353
     3.50      175635    6620      6620      100.0%      21.9%     21.7%   175635   18.53    22.3%    99.6*    -5    0.775    5931
     3.00      315212   11739     11739      100.0%      89.6%     92.8%   315212    4.85    91.3%    95.9*    -3    0.713   10675
     2.95       44353    1634      1634      100.0%     196.5%    209.5%    44353    2.32   200.3%    83.5*    -2    0.663    1494
     2.90       46859    1725      1727       99.9%     259.1%    275.3%    46859    1.78   264.0%    73.4*     0    0.654    1586
    total      935917   35585     35602      100.0%       9.9%     10.3%   935916   25.37    10.1%   100.0*    -4    0.736   31332
Figure 3.11.: Processing statistics of native DCTN1412-533-IC2-47 Excerpt was
taken from XSCALE.LP.
3.4. Phase solution with selenomethionine
A multi-wavelength anomalous diffraction measurement (MAD) of a crystal with in-
corporated selenomethionine was conducted to solve the phase problem. For this ex-
periment a fluorescence scan was performed to determine the absorption peak and the
point of inflection and remote of the absorption curve of Se. Then, a dataset each at
wavelengths 0.979060 Å (peak), 0.979650 Å (inflection), and 0.971380 Å (remote) of
the same crystal was recorded. The datasets were processed with XDS (Kabsch, 2010)
as described in subsection 2.10.1.
The three datasets were merged and prepared for phase solution in XPREP. In order
to determine a cut-off for the anomalous signal the anomalous signal-to-noise ratio was
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calculated for different resolution ranges for all three datasets. As a rule of thumb
the data should be cut at the resolution where the anomalous signal-to-noise drops
below 1.3. In figure 3.12 the processing statistics calculated by XPREP are shown
and it demonstrates that in the remote dataset anomalous signal is only reliably de-
tectable until 6 Å. The peak dataset, which was recorded first, exhibited anomalous
signal up to 4.6 Å. At this point it got apparent that especially the last recorded re-
mote dataset exhibited radiation damage. Therefore, instead of solving the phases
with MAD, single-wavelength anomalous diffraction (SAD) was employed using the
anomalous signal from the peak dataset alone.
Dataset  1   f' = -7.381   f" =  3.840  XDS_ASCII_PK.HKL
 Anomalous signal/noise ratios (1.0 is random).  The first line is based on
 input sigmas, the second on variances of F+ and F
-
 (if not already averaged):
 Inf - 8.0 - 6.0 - 5.2 - 5.0 - 4.8 - 4.6 - 4.4 - 4.2 - 4.0 - 3.8 - 3.6 - 3.4 A
    4.40  2.33  1.69  1.68  1.75  1.63  1.52  1.42  1.51  1.38  1.17  1.08
    3.86  2.08  1.47  1.47  1.46  1.38  1.28  1.22  1.27  1.18  1.07  1.08
Dataset  2   f' = -7.500   f" =  2.000  XDS_ASCII_IP.HKL
 Anomalous signal/noise ratios (1.0 is random).  The first line is based on
 input sigmas, the second on variances of F+ and F- (if not already averaged):
 Inf - 8.0 - 6.0 - 5.2 - 5.0 - 4.8 - 4.6 - 4.4 - 4.2 - 4.0 - 3.8 - 3.6 - 3.4 A
    2.86  1.68  1.41  1.94  1.89  1.82  1.78  1.62  1.60  1.43  1.09  0.99
    2.29  1.45  1.23  1.43  1.37  1.29  1.26  1.16  1.19  1.12  1.02  1.02
Dataset  3   f' = -4.177   f" =  3.773  XDS_ASCII_RM.HKL
 Anomalous signal/noise ratios (1.0 is random).  The first line is based on
 input sigmas, the second on variances of F+ and F- (if not already averaged):
 Inf - 8.0 - 6.0 - 5.4 - 5.2 - 5.0 - 4.8 - 4.6 - 4.4 - 4.2 - 4.0 - 3.8 - 3.6 A
    2.96  1.62  1.26  1.42  1.66  1.73  1.59  1.59  1.44  1.46  1.17  0.96
    2.39  1.40  1.15  1.19  1.24  1.24  1.18  1.18  1.08  1.12  1.04  0.96
Figure 3.12.: Processing statistics from MAD Excerpt was taken from XPREP
documentation file. Underlined in green are the last figures before the anoma-
lous signal-to-noise ratio drops below 1.3, at which point the resolution cut-
off is recommended.
After preparing the peak dataset with XPREP SHELXD (Sheldrick, 2010) was run
to find the heavy-atom positions. The number of molecules in the asymmetric unite
was estimated with Bernhard Rupps Matthews probability calculator http://www.
ruppweb.org/mattprob/default.html (Kantardjieff and Rupp, 2003, Matthews, 1968).
The most probable number of molecules for the hetero-tetramer DCTN1412-533-IC2-47
was 4 with an overall probability of 54% and a solvent content of 46.5%. Each hetero-
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tetramer contains 10 selenomethionine (SeMet) positions, which equals to 40 positions
in total. A search for 40 SeMet positions was started and 56 heavy-atom positions
were found by the programme of which only 15 seemed to be of significance. As can be
seen in figure 3.13 there is a drop in the graph after peak number 15, which indicates
the last significant occupation site. A later examination of the heavy-atom positions















Figure 3.13.: Graph of the heavy atoms found in the peak dataset. The graph
shows the heavy-atom occupancy versus the peak number. The green arrow
indicates the last significant site of heavy-atoms.
Based on the afore calculated reference phases from heavy-atoms SHELXE estimated
the electron density map of the complete macromolecule and improved the phases by
density modification. Furthermore, it extended the phases to 3.4 Å since the peak
dataset showed good statistics up to this resolution. Because the systematic absence
of reflections pointed to spacegroup P41212 as well as its enantiomer P43212 two maps
(called ’original’ and ’inverted’, respectively) were calculated. As can be seen in figure
3.14 the ’original’ map depicts the electron density of α-helical structures whereas the




Original map           Inverted map
Figure 3.14.: Maps calculated by SHELX. (Left) Shown is the map calculated in
spacegroup P41212. α-helical structures are visible, which indicates that
the map is correct (Right) This map was calculated based on spacegroup
P43212. There are no interpretable structural elements.
3.5. Model building
For modelling a structure into the electron density map the program ACMI (DiMaio
et al., 2007), which is specialized on low resolution modelling, was applied. The cal-
culation of models was carried out in three sub-steps as described in subsection 2.10.3
and took almost two weeks. Two runs were started with differing sequence inputs. On
the one hand, the input file contained eight chains each of DCTN1412-533 and IC2-47,
which is based on the aforementioned calculated Matthews probability (see section
3.4), which estimated that four molecules of the hetero-tetramer DCTN1412-533-IC2-47
are in the asymmetric unit. On the other hand, only eight chains of DCTN1412-533 were
written in the second sequence input file. The second input file was based on the find-
ings that a dissolved crystal applied on SDS gel only gave one band for DCTN1412-533
while the IC2-47 band was almost invisible.
After the first two runs were finished two things became clear. One was that only
DCTN1412-533 amino acid sequences were built into the electron density map. And sec-
ondly, less than eight chains were built. Therefore, the results from the first run were
dismissed and only the 20 built models from the DCTN1412-533 run were inspected.
All models were checked in Coot (Emsley and Cowtan, 2004, Emsley et al., 2010) and
the longest α-helical chains were copied into one pdb-file. Symmetry related atoms
were visualized in Coot to ascertain the number of chains there are in the asymmetric
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unit 1. Based on this approach five α-helices were found to fill the entire asymmetric
unit. The chosen chains can be seen in figure 3.15.
Figure 3.15.: Models calculated by ACMI and the chains that were chosen
for the initial model. The α-helical chains, which are coloured in blue,
were chosen as substructure for building the entire model.
These chains were consequently all moved into the electron density of the same asym-
metric unit to simplify further work on the structure using shift molecules in the soft-
ware suite CNS (Brünger et al., 1998). Altogether, 67.5% of the five DCTN1412-533-
helices were built with ACMI. Four of these chains form two coiled-coils (chains A/B
and C/D) while the fifth α-helix forms a coiled-coil with its symmetry equivalent.
The chains were extended by using the model building tool Place helix here in Coot
to fill the remaining electron density. The first 20 to 25 amino acids of DCTN1412-533
could not be built in since no electron density was visible. Also, during the first round
of model building hardly any side-chain electron densities were visible. After a few
rounds of refinement with Refmac (Version 5.7.0029) (CCP4, 1994, Murshudov et al.,
2011) using restrained refinement, local NCS, and Babinet scaling for the resolution
range 50-3.4 Å and subsequent model building the overall appearance of the α-helices
got more defined. The electron density for side-chains got more pronounced but no ad-
ditional electron density, which could account for IC2-47 appeared. Several side-chains
(especially at the N- and the C-terminus) could not be confidently placed in the elec-
1The asymmetric unit is the part of the unit cell that contains all the structural information and by
applying symmetry operators reproduces the unit cell.
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tron density map. In particular, long side-chains as present in lysines or glutamic acids
exhibited only partial electron densities. In addition, the fifth chain (E), which forms
a coiled-coil with its symmetry equivalent (E’), exhibits chain breaks in the electron
density between amino acids Arg479 and Glu491. In the final rounds of model building
the MolProbity server (Chen et al., 2010) was used for validating the geometry of the
structure. If applicable, changes were carried out on the structure. The final value of
the residual factor (Rwork) decreased to 28.2% after an initial 33% after the first refine-
ment round. The final value of the free residual factor (Rfree), which was calculated
from 5% of the reflections that were not included into the refinement cycles, reached
30.6% (initially, 35%).
3.5.1. Molecular replacement with DCTN1412-533-IC2-47
dataset taken from crystal grown at pH 7.3
One dataset was taken from a crystal derived from DCTN1412-533-IC2-47 after dialysis
using seeding. Other than the derivative and native DCTN1412-533-IC2-47 crystals this
crystal grew at pH 7.3 and diffracted to 3.4 Å. The dataset was processed with XDS
and displayed similar cell parameters like the derivative dataset (a = b = 156.82, c =
133.08, α = β = γ = 90°). Molecular replacement using Phaser MR (McCoy et al.,
2007) implemented in the CCP4 program suite and the DCTN1412-533 coiled-coil struc-
ture as search model was performed to solve the phases. The resulting model was
refined in Refmac. Electron density which could have accounted for the dynein IC did
not appear near DCTN1412-533 .
3.5.2. Extending phases to new native dataset
For a large number of native crystals no better diffraction than the one found in the
derivative crystal dataset could be measured. Most crystals showed diffraction between
6 and 3.5 Å and no additive screen or other construct could improve that. Finally, a
native crystal diffracted until 2.9 Å (see subsection 3.3 for crystallization condition and
data processing statistics). The structure coordinates based on the 3.4 Å-dataset was
refined in Refmac against the new 2.9 Å-dataset (resolution range 2.9-50 Å) using TLS
& restrained refinement, local NCS and Babinet scaling. The new electron density
map shows more features for side-chains, which can be seen in figure 3.16. Due to the
better resolution of the map several side-chains could be placed with more confidence.
However, most of the first 20 to 25 amino acids of the N-terminus were still not visible
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and no electron density for IC2-47 appeared. Also, the chain breaks in the map in the
middle of chain E (Arg479 and Glu491) showed no improvement.
3.4 Å 2.9 Å
1 σ 1 σ
Figure 3.16.: Electron density map at 3.4 and 2.9 Å Exemplarily for other amino
acids, the electron density maps at 3.4 and 2.9 Å of glutamic acid 473 is
shown. Both maps are contoured at 1 σ.
Subsequently, the structure was improved in Coot and refined in Refmac in several
cycles. The final Rwork and Rfree values are 0.259 and 0.281, respectively. An overview
of the crystal data and refinement statistics can be found in section 3.1. The analysis
of the structure was performed with MolProbity. It showed a good overall geometry
with 98.57% of the amino acids in the favoured region of the Ramachandran plot and
the rest in the allowed region.
Table 3.1.: Crystal data and refinement statistics
Derivative crystal Native crystal
Crystal data
Space group P41212 P41212
Cell parameters
a, b, c [Å] 156.34, 156.34, 131.14 155.32, 155.32, 129.26
α, β, γ [°] 90, 90, 90 90, 90, 90
Resolution [Å] 50-3.4 (3.6-3.4) 40-2.9 (2.94-2.9)
Completeness of data [%] 99.4 (96.7) 100 (99.9)
Unique reflections 42,432 35,585
Multiplicity 6.2 (5.9) 26.3 (27.2)
CC1/2 100 (73.4)
<I/σI> 8.21 (1.87) 25.37 (1.78)
44
3.6. Overview of the structural characteristics of the DCTN1412-533 coiled-coil
Table 3.1: Crystal data – continued from previous page





Bond length [Å] 0.015
Bond angle [°] 1.616
Number of atoms 4102
Average B-factor [Å2] 109.77
Ramachandran
in favoured regions [%] 98.57
in allowed regions [%] 1.43
3.6. Overview of the structural characteristics of
the DCTN1412-533 coiled-coil
The final model consists of five α-helical chains (A → E) with a total of 488 amino
acids and has a Matthews coefficient of 6.79 Å3/Dalton, which corresponds to a solvent
content of 81.74%. Water molecules were not placed into the model due to the low res-
olution. The five chains of DCTN1412-533 start between amino acids Glu431 and Leu436
and end between Gln530 and Glu532. There was no electron density for the first 19-24
amino acids and the last 1-3 residues. Chains are between 94 and 100 amino acids in
length, with chain E forming the shortest helix. Chains A/B, C/D, and E/E’ each form
a left handed parallel homodimeric coiled-coil as depicted in figure 3.17 A. Analyses
with Socket (Walshaw and Woolfson, 2001) and Twister (Strelkov and Burkhard, 2002)
were conducted to check whether the DCTN1412-533 coiled-coils exhibit a continuous
heptad motif typical for coiled-coil structures. No stutters or stammers that would re-
sult in local distortions of the geometry and that are implicated by interruptions in the
heptad motif could be found. Both programs marked the corresponding amino acids
with the same letter (abcdefg) of the heptad motif. All in all, each α-helix consists of
14 continuous heptad motif repeats. Furthermore, Twister calculated that the average
turn of the α-helix depending on the coiled-coil consists of 3.60 to 3.63 residues and the
α-helical rise per residue is 1.51 Å (1.52 Å for E/E’). The most pronounced difference
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between the three coiled-coils were found in the coiled-coil pitch 2. Chains C/D exhibit
the smallest pitch with 149.9 Å followed by coiled-coil A/B with 152.0 Å. Chains E/E’
display the largest coiled-coil pitch with 158.5 Å.
As shown in figure 3.17 B, the asymmetric unit is made up of five helices. All of them
exhibit the same N → C direction. Coiled-coils A/B and C/D are positioned on each
end of helix E in an obtuse angle (130° - 150°).
A






Figure 3.17.: Overview of the solved DCTN1412-533 coiled-coil structure. (A)
Shown are the three coiled-coils made up of chains A/B (blue), C/D (green)
and E with its symmetry mate (E’)(red). They have an average length of
145 Å. (B) The location of the coiled-coils in the asymmetric unit.
An analysis of the heptad positions in the structure (see appendix C.1 for a helical
wheel representation) was carried out. The hydrophobic positions a and d also con-
tain polar, uncharged amino acids like glutamine and asparagine as well as a charged
glutamic acid (Glu475). A total of 28.5% non-hydrophobic amino acids occupy these
positions. 59% of the preferentially charged positions e and g are populated by hy-
drophobic and polar, uncharged amino acids. Positions b, c, and f can be occupied
by any amino acid. In DCTN1412-533 half of these positions are filled with negatively
charged glutamic acid and aspartic acid, 14.8% are positively charged, 24% are hy-
drophobic residues and the rest is occupied with polar, uncharged amino acids.
2Coiled-coil pitch is the length of a coiled-coil in which it makes one complete turn.
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Figure 3.18.: Graphical representation of the coiled-coils radii. The radii of
the three coiled-coils determined by Twister are depicted in dependence on
the residue. Coiled-coils A/B, C/D and E/E’ are coloured in red, blue, and
green, respectively.
Furthermore, the coiled-coil radii calculated with Twister were examined. The distance
between the helical axes in coiled-coils A/B and C/D range from ≈8.7 to 11.4 Å with
a mean distance of ≈10 Å. Chains E/E’ display a distance range of ≈9.2 to 12.4 Å
and a mean distance of 10.2 Å. As can be seen in figure 3.18 the coiled-coil radii of
A/B and C/D proceed similarly. An N-terminal stretch of four canonical leucines in
d -positions (Leu436, 443, 450, 457) and mostly valines in a-position (Val433, Val447,
Val454; Asn440) fluctuates slightly around the mean radius of 5 Å. A second area which
displays mean radii is located at the C-terminus (residues 503-523) of the fragment and
contains canonical hydrophobic as well as polar residues (Val503, Ile510, Thr517 in a
and Tyr506, Tyr513, Leu520 in d). There are also two distinct features in the graph
that deviate from the mean radius. One is a peak with higher radii up to 5.7 Å between
residues 455 (459 for coiled-coil A/B) and 483. In this area there are non-hydrophobic
residues in positions a and d (Asn461, Gln468, Glu475 in a and Asn464 in d). This
peak is followed by a drop in cc-radius (4.4 Å) between residues 483-505. Here, position
d is occupied with a cluster of alanines (Ala485, Ala492, Ala499). E/E’ on the other
hand only roughly follows a similar radii course. Like the other coiled-coils there is a
rise in cc-radius starting at residue 457 but the increase is shallower. However, instead
of decreasing like in A/B and C/D the radii sharply increase until residue 483 (6.3 Å).
It then drops to 4.7 Å at residue 499 before rising again. There is also a higher radius
at the C-terminus (> 5.5 Å), which can be found in every coiled-coil.
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All three coiled-coils exhibit a similar almost straight shape. The question arose how
much they differ from each other. Therefore, the main-chain of the structures were su-
perimposed using least square fit of residues Met432 to Glu465 in Coot. Chains C and
E from coiled-coils C/D and E/E’, respectively, were superimposed on helix A. They
both gave low root-mean-square deviations (r.m.s.d.), 0.487 and 0.364 Å for chains C
and E, respectively. Superimposing residues 432 to 465 of Chain D to A led to a higher
r.m.s.d. value (1.13 Å). Hence the superimposition of C to A was preferred. Since E’
is the symmetry mate of helix E both superimpositions gave identical results.
Figure 3.19 shows the superimposition from the side and from the front (C-terminus).
While coiled-coil E/E’ lies in the middle, A/B and C/D each bend in opposite direc-
tions away from E/E’. Superimposing 3 coiled-coils A/B and C/D on E/E’ result in a
maximum Cα distance of 23.93 and 19.11 Å, respectively. The maximum distance of
C/D to A/B is 35.26 Å. The minimum and average distances can be seen in table 3.2.




minimum maximum average whole main-chain
C/D → A/B 1.38 35.26 13.98 2.36
A/B → E/E’ 1.47 23.93 11.42 1.28
C/D → E/E’ 0.09 19.11 6.33 2.17
In order to analyse the bending of A/B and C/D the programme CCBENDS (Brown,
2010) was employed. Only those residues at which the size of the local axis bend was
a peak and greater than 3° were considered. For coiled-coil A/B a 3.9° and a 4.8° bend
was found at residue Leu482 and Ala504, respectively. The direction of bend is -8.6°
for the first and -166.2° for the second residue. Coiled-coil C/D contained bends at
similar positions. At residue Leu482 a 5.1° and at Asp505 a 6° bend was detected which
display a direction of bend of 7.5° and -143.2°, respectively. No bends were found in
coiled-coil E/E’.
3This was done in PyMol using the Phyton script color by rmsd by Shivender Shandilya, Jason
Vertrees, and Thomas Holder.
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Figure 3.19.: Superimposition of the three coiled-coils. Residues 432 to 465 of all
three coiled-coils were superimposed in Coot to see differences in the overall
shape. (Left) View of the superimposition from the side and (Right) from
the front of the C-terminus.
Furthermore, B-values, which are a measure of residue flexibility 4, were mapped on
the structure. The Cα B-factors and the residue B-factors vary between 50 and 220 Å
2
and between 40 to 240 Å2, respectively. Since several side-chains are only insufficiently
supported by electron density only Cα B-factors were considered. All helices feature
regions at both termini with lower B-factors as depicted in figure 3.20 A in blue. They
correspond to crystal contacts. The middle and the ends of all helices show higher
B-values depicted in green to red. The areas coloured in yellow to red coincide with
poorer electron density partly resulting in chain-breaks. In contrast to the other two
coiled-coils, E/E’ exhibits very high B-values in the middle. This can also be seen in
graph 3.20 B where helix E shows an overall higher B-value between residues 466 to 495
5. All helices show a decrease of main-chain B-values around residues 452 to 462 and
505 to 515, except for chain B, which exhibits hardly any decrease in the second region.
The two crystal contact regions with lower B-values contain polar contacts 6 between
coiled-coils in these areas. These contacts are visualized in figure 3.21. Most of them
are hydrogen bonds that are characterized by residues that donate their covalently
bound hydrogen to a negatively charged acceptor atom. Examples are hydrogen bonds
formed between Asp456/E and Tyr513/B, Glu445/E and Gln507/A, and Tyr506/E
and Glu452/D. Furthermore, Glu501/E forms a salt bridge with Arg451/C which oc-
curs between amino acids of opposite electron charges. In general, one can say that
there are polar contacts between the C-terminal region of chains A and B with the
N-terminal area of chain E. The N-terminal regions of chains C and D are in contact
with the C-terminal area of helix E. Likewise, there are polar contacts between the
4Low B-values indicate well order regions while higher B-values are a sign of high flexibility or
disorder.
5B-factor values of the main-chain were extracted from the pdb-file using the program Baverage in
CCP4 (CCP4, 1994).
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Figure 3.20.: Representation of B-factors. (A) Cα B-factors are mapped on the
structure. Each coiled-coil shows areas of lower (blue to green) and higher
flexibility (yellow to red). In contrast to coiled-coils A/B and C/D, E/E’
shows very high flexibility in the middle. (B) Graphical representation of
main-chain B-factors of the five helices against the residue numbers.
C-terminal regions of coiled-coil C/D and the N-terminal area of chains A and B with
symmetry mates.
Hydrogen bonds can be found throughout the structure. This is especially true for
the single helices because they are stabilized by hydrogen bonds. The C=O group of
an amino acid forms a hydrogen bond with the N-H group of the amino acids four
residues apart. There are a few intra as well as inter side-chain side-chain polar con-
tacts. For example, both Asn524 in chains A and B form a hydrogen bond as well as in
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chains C and D. Salt bridges are found between Arg488/C and Glu493/D and between
Arg488/A and Glu493/B (shown in figure 3.22). All in all, there are about eight polar
intramolecular contacts in each coiled-coil. However, if the cut-off for polar contacts is
reduced from 3.6 Å (default in PyMol) to 3.2 Å only one contact each remains. In the
case of coiled-coil A/B it is a hydrogen bond between Asn461-Asn461 and coiled-coil
C/D still has a salt bridge between Arg488/C and Glu493/D. If the cut-off is further re-
duced to 3.0 Å no interaction remains between the helices. Interestingly, polar contacts
between coiled-coils that form the crystal contacts are slightly diminished in number
but still a total of seven contacts remain. It appears, that on average, inter-coiled-coil
polar contacts are stronger than intra-coiled-coil bonds.
In a further step to examine the structure the electrostatic surface of the coiled-coil
was generated using PyMol. Based on the calculated pI (pI: 4.4) is was expected that
DCTN1412-533 would display an overall negatively charged electrostatic surface. As can
be seen in figure 3.23 the N-terminal region displays a large elongated band of nega-
tive charge from Glu434 to Asp483. Two further negatively charged patches can be
found around Glu501 and Glu532. Positively charged areas can be seen around Arg451,
Lys494, Lys511 to Arg514, and Arg525. Altogether it can be said that the molecule is
indeed predominantly negatively charged.
In order to see if this negatively charged area is only found in chicken DCTN1412-533 or
if this is typical for all DCTN1 proteins a weblogo (Crooks et al., 2004, Schneider and
Stephens, 1990) 7 of a DCTN1 alignment containing 236 sequences was created. In
figure 3.23 B the whole DCTN1412-533 weblogo with the corresponding alignment posi-
tions is depicted. The area representing the solved structure is coloured in light grey.
The asterisks in the image highlight conserved hydrophobic residues, which are found in
positions a and d of the heptad motif. The weblogo shows a well conserved N-terminus
of DCTN1412-533 up to alignment position 952 (Asp483 in chicken DCTN1412-533) con-
taining many conserved acidic amino acids. This corresponds to the surface area that
displays an elongated negatively charged band. Compared to the aforementioned re-
gion the following area mainly depicts less residue conservation. Exceptions are for
example some conserved acidic amino acids at positions 960 (Glu491), 970 (Glu501),
and 974 (Asp505) and alkaline residues at positions 981 (Lys512) and 983 (Arg514).
Furthermore, threonine (Thr509) at alignment position 978 seems to be of great impor-
tance since it is highly conserved. A look into the polar contacts of the DCTN1412-533
structure reveal a potential intramolecular hydrogen bond between Thr509 and the
backbone oxygen of Asp505, which is also conserved within the eukaryotes.



















Figure 3.21.: Polar contacts between coiled-coils. Polar contacts are indicated
by yellow dashed lines. (A) Hydrogen bonds between coiled-coil A/B and
helix E are shown. (B) Hydrogen bonds and a salt bridge (Glu501/E and
Arg452/C) found between coiled-coil C/D and helix E are depicted.
3.7. Characteristics of dynein intermediate chain
In contrast to DCTN1412-533, IC2-69 has a calculated pI of 9.3 (IC2-47: pI = 9.7, IC2-84:
pI = 9.2). It has therefore a charge opposed to DCTN1412-533 suggesting an electro-
static interaction between those two molecules.
The N-terminal region of IC is characterized by many alkaline amino acids. This is not
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Figure 3.22.: Polar contacts within coiled-coils C/D. These polar contacts can
also be found in coiled-coil A/B. Polar contacts are indicated by yellow
dashed lines. (A) Hydrogen bonds between asparagines. (B) Salt bridge
between Arg488 and Glu493.
just the case for human IC but can be found throughout the eukaryotes. A weblogo was
created to illustrate the conservation of amino acid positions in the N-terminus of IC.
It consists of 175 cytoplasmic IC sequences from 142 species which range from fungi,
frogs, birds to vertebrates. Figure 3.24 A shows the weblogo of the first 122 alignment
positions as well as the amino acid sequence of Drosophila melanogaster and of the
two human cytoplasmic IC isoforms. Two conserved regions (alignment positions 8-42
and 62-86) indicated by high, wide stacks are apparent. They are separated by a less
conserved region, which is illustrated by smaller stacks. Especially, the first region con-
tains many conserved arginines, lysins as well as conserved leucines and glutamic acids
which can also be seen by comparing the human and D. melanogaster sequences. The
second region also contains alkaline and acidic amino acids and some moderately con-
served glycine and proline positions. Towards the C-terminus of the sequence section
several more proline and glycine positions show some degree of conservation. These
amino acids are known to disrupt α-helical structures. Accordingly, it would be ex-
pected that the first 69 amino acids of IC bind to the negatively charged regions of
DCTN1412-533.
Of interest are the alternatively spliced exons in the N-terminal regions of the two
isoforms of human IC localized upstream of the two DCTN1 binding regions. They are
conserved among other species like chicken, dog, and the pufferfish Takifugu rubripes.
They have previously been reported in mice IC and showed tissue-specific expressions
Kuta et al. (2010). Both human isoforms contain differentially included exons starting
after amino acid 74 and 75 in IC1 and IC2, respectively (see figure 3.24 B). Both con-
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Figure 3.23.: Electrostatic surface charge and sequence conservation of
DCTN1412-533 coiled-coil. (A) The electrostatic surface was calculated
in PyMol. Red areas represent negatively charged areas whereas blue depicts
positive surface patches. The image below shows the molecule rotated by
90° around the x-axis. (B) This weblogo of DCTN1412-533 illustrates the
sequence conservation of 236 protein sequences. The overall stack height
indicates the sequence conservation at that position while the height of the
single amino acids at the position show the relative frequencies of the sym-
bols. The width illustrates valid symbols at that positions (many gaps lead
to thinner stacks). The N-terminus is well conserved up to position 952,
which is equivalent to chicken Asp483. The C-terminus is less well con-
served. However, there are some acidic and alkaline residues that show high
conservation. The asterisks show conserved positions that correspond to a
and d of the heptad motif.
and 18 aa in IC1 and IC2, respectively) and in sequence. For this exon an alternative
3’ splice site is used leading to an extended boundary of the downstream exon. In front
of this differentially included exon IC2 also contains a 7 aa long exon (orange), which
is subject to exon skipping. Both differentially included exons lead to differing lengths
(from 0 to 17/18 to 25 aa) between two proline-containing sequence sections.
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Dm    1
For clarity introns have been scaled down by a factor of 160.37
1 gi|224589819|ref|NC_000007.13| (292861bp)
400 bps (ex.) 72000 bps (in.)
75 92
For clarity introns have been scaled down by a factor of 30.11
1 gi|224589811|ref|NC_000002.11| (57731bp)
500 bps (ex.) 13800 bps (in.)
82 100
76
Dynein intermediate chain 1





Dm    47
Figure 3.24.: Sequence analysis of IC. (A) The weblogo shows the IC sequence con-
servation of the N-terminal region. For the calculation of the weblogo 175
sequences from 142 species were used. The overall stack height indicates the
sequence conservation at that position while the height of the single amino
acids at this position show the relative frequencies of the symbols. The
width illustrates valid symbols at that position (many gaps lead to thinner
stacks). Altogether, there are two conserved regions. Underneath the logo
are the sequences of human IC (Hs, isoforms A and B) and of Drosophila
melanogaster (Dm). (B) The two isoforms of human cytoplasmic IC with
their alternatively spliced exons in the N-terminal region were created with
WebScipio (Hatje et al., 2013). Introns are illustrated in light grey and ex-
ons in dark grey. The alternatively spliced exons are coloured in green and
orange. The green exons in both isoforms have a similar sequence and they
are both spliced by an alternative 3’ splice junction. The numbers indicate
the respective start position of the exon in the amino acid sequence.
Secondary structure prediction tools like Marcoil (Delorenzi and Speed, 2002) and
Logicoil (Vincent et al., 2013) all predict a coiled-coil structure for the first 44 to 67
amino acids of the N-terminal IC. Examining the amino acid sequence of IC gves rise
to the question if it really forms coiled-coils since it does not feature a typical heptad
motif. It is not uncommon for prediction tools to predict charged single α-helices as
coiled-coils (Peckham and Knight, 2009, Süveges et al., 2009).
A web tool, called WaggaWagga (http://www.motorproteine.de/waggawagga, Do-
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minic Simm), examines protein sequences for their propensity to form charged single
α-helices (CSAH) instead of coiled-coils. CSAH are characterized by a lack of a hy-
drophobic seam caused by charged amino acids in positions a and d of the heptad motif
(Peckham and Knight, 2009). Coiled-coils on the other hand contain 75-80% apolar
amino acids in these positions (Conway and Parry, 1990) leading to the formation of
the hydrophobic seam.
The result for IC1-69 derived from the WaggaWagga web application can be seen as a
so-called heptad net in the top of figure 3.25. It shows that positions a and d while
containing some hydrophobic amino acids are mainly filled by charged amino acids.
This leads to many strong and weak interactions between oppositely charged amino
acids, which are known to stabilize CSAH. It seems unlikely that a hydrophobic seam
can develop under these conditions. In contrast to IC, DCTN1412-533 features apolar
amino acids in positions a and d (see figure 3.25 bottom). Except for one glutamic
acid in position a (Glu475), all charged residues are found in the remaining heptad
positions. There are only a few predicted interactions between charged residues within
the α-helix. Furthermore, the overall percentage of charged residues is higher in IC1-69.
In DCTN1412-533 41.3% of all residues are charged (R, K, D, and E) whereas in the
putative single α-helix IC1-69 56.4% are charged. Taking these findings together, it is
possible that the two ICs of dynein form single α-helices instead of a coiled-coil.
3.8. Chemical cross-linking of DCTN1412-533-IC2-47
and DCTN1412-533-IC2-69
Although dynein IC was part of the purified complex and hence part of the crystal-
lization set up it was not present in the electron density map. Therefore, chemical
cross-linking in combination with mass spectrometry was chosen to find out where IC
interacts with DCTN1.
For the reaction the crosslinker BS3 was selected. It contains two reactive groups (N-
hydroxysulfosuccinimide ester) at each end of a 11.4 Å spacer arm. The ester groups
react with amino groups found in lysines and at the N-terminus at pH 7-9 to form sta-
ble interactions. Due to the length of the spacer long distances between the interacting
proteins can be bridged.
Two constructs, DCTN1412-533-IC2-47 and DCTN1412-522-IC2-69, were used for this ex-
periment. Each IC2-47 molecule contains 12 lysine positions and each IC2-69 protein 13
lysine positions as potential cross-linking sites. The DCTN1412-533 monomer features
only six lysines. At first, 70-100 pmol of the protein complex were cross-linked with
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Figure 3.25.: WaggaWagga results for IC1-69 and DCTN1412-522. On the left
side the amino acid sequence with their corresponding heptad position is
shown. On the other side a heptad net is depicted to give a 2-D representa-
tion of the helix by opening up along a α-helical seam and flattening it out.
Thereby, the hydrophobic seam formed by a and d is located in the middle
of the net. Charged residues are coloured in red (E, D) and blue (R, K).
(Top) IC1-69 shows many charged residues in positions a and d and several
interactions between these amino acids. Since there are hardly any apolar
residues in these positions the formation of a hydrophobic seam seems un-
likely. Therefore, a CSAH could be a possibility. (Bottom) The coiled-coil
DCTN1412-522 shows a distinct hydrophobic seam caused by apolar residues
in positions a and d and only a few interactions.
increasing amounts of BS3 (0, 25, 62.5, 125, 250, 500, and 1000 µM) to determine
which concentration was sufficient for a good cross-linking result without producing
unspecific links. 125 and 250 µM produced the best results. So all subsequent ex-
periments were performed with these concentrations. All in all, DCTN1412-533-IC2-47
protein was used for two experiments (125 and 250 µM BS3) and DCTN1412-533-IC2-69
for four experiments (two each with 125 and 250 µM BS3) resulting in a total of six
replicas. Samples were prepared as described in section 2.11. The appropriate bands
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corresponding to DCTN1412-533 cross-linked with IC (see figure 3.26) were cut from the
gel. They were then digested with trypsin and the resulting peptides were extracted
from the gel pieces and analysed via mass spectrometry as described in section 2.11.
The search for cross-links was performed with pLink (Yang et al., 2012).
 DCTN1412₋533/IC2₋47                    DCTN1412₋533/IC2₋69
















Figure 3.26.: BS3 cross-linked DCTN1412-533-IC2-47 and IC2-69. Shown are
17.5% SDS gels with cross-linked DCTN1412-533-IC2-47 and DCTN1412-533-
IC2-69 as well as the non-cross-linked protein complex on the far right of
each gel. The orange brackets indicate the bands that were cut from the gel.
Figure 3.27 shows the result of the performed cross-link experiments. Every link that
is shown in a black dashed line was found at least once in at least two samples. The
exceptions are indicated by a number sign, a asterisk, and a plus and will be explained
further down. Example fragmentation spectra for each link can be found in appendix
C.2.
The top image (figure 3.27 A) depicts intramolecular links found in dynein IC. BS3
formed links between lysines 7 and 13, 27 and 33, and 27 and 34. While the first
two links were identified three and four times, respectively, the last one was found 21
times in all experiments. Assuming a canonical α-helical structure for the N-terminus
with 3.6 residues per turn and 5.4 Å between two turns one can estimate a helical rise
of 1.5 Å between two residues. Based on these assumptions none of the cross-linked
lysines are more than 10.5 Å apart. Hence, the cross-links are well within the range
of the 24 Å (Lys-BS3-Lys) that can maximally be bridged (Yang et al., 2012). Since
the excised protein band should only contain a DCTN1-IC heterodimer the links found
here are on one molecule and not between two IC molecules.
The lower image (figure 3.27 B) shows the intermolecular links found between IC and
DCTN1. A total of nine links were discovered, many of which were found in more
than two out of the six conducted experiments. However, the link marked with # was
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Figure 3.27.: Graphical overview of the cross-link results. (A) Intramolecu-
lar cross-links found in IC. (B) Intermolecular cross-links found between
IC and DCTN1. The link marked with a ”*” was only found twice in
one DCTN1412-533-IC2-69 sample. The
”#” sign indicates a link that was
found in DCTN1412-533-IC2-47 samples alone. The
”+” was found in two
DCTN1412-533-IC2-69 samples only. The black dashed lines connect the
lysines (blue line) between which the cross-links were found. The numbers
indicate the positions of lysines in the corresponding sequence.
only found in DCTN1412-533-IC2-47 samples, whereas * indicates a link identified only
twice in one DCTN1412-533-IC2-69 sample and
+ is a cross-link found in only two separate
DCTN1412-533-IC2-69 samples. The first two links found between both molecules are IC-
N and DCTN1-Lys446, and IC-Lys3 and DCTN1-Lys446. Each link was only found in
DCTN1412-533-IC2-69 and DCTN1412-533-IC2-47 samples, respectively. The lysine triplet
Lys24/25/27 of dynein IC all cross-linked to DCTN1-Lys446 with six, three and nine
spectra, respectively, to support each link. The next IC lysine triplet (Lys32/33/34) ex-
hibited cross-links to DCTN1-Lys446 as well as DCTN1-Lys494. In detail, Lys34 only
linked to Lys446 of DCTN1. However, Lys33 showed cross-links to both (Lys446 and
Lys494). Even though the Lys33-Lys446 link is only supported by two fragmentation
spectra found in two DCTN1412-533-IC2-69 samples, Lys33-Lys494 and Lys34-Lys494 are
backed up by more than five spectra each found in different experiments. Due to the
distance between Lys446 and Lys494 these cross-links could not have co-existed at the
same time but this will be explained later in the discussion chapter. The last link was





4.1. Constructs DCTN1412-533-IC2-47 and
DCTN1412-533-IC2-69 produced crystals
Four constructs have been designed to address the question of the dynein-dynactin
interaction. These constructs are essentially based on two studies (Morgan et al., 2011,
Siglin et al., 2013) that describe new features about the interaction site. The first con-
struct, DCTN1412-533-IC2-47 , based on gel shift experiments with rat IC and DCTN1 of
differing lengths (Siglin et al., 2013), produced house-like crystals that showed diffrac-
tion up to 2.9 Å. However, a certain amount of IC always got lost during protein purifi-
cation. To counteract the loss the His-tag formerly on the N-terminus of DCTN1412-533
was transferred to the N-terminus of IC2-47. Subsequent purification steps followed by
inspection on SDS gels now showed equal amounts of both proteins. Because IC2-47 is so
small that the 8× His-tag might unfavourably interfere with crystallization a TEV-site
was implemented for subsequent removal. Interestingly, crystals appeared after four
months only in set-ups with the His-Tag still attached to IC. However, the resolution
was too low (20 Å) to work with the dataset. No crystals developed with His-tag-
free protein. Published examples of protein structures where a His-tag was essential
for crystallization are rare. In the case of Tajika et al. (2004) the C-terminal His-tag
protruded outside the molecule and packed with another molecule, which the authors
assumed might have been important for crystallization. Crystals with native (His-tag
free) protein could not be produced. However, in more than 90% of His-tagged solved
models the tag was not visible in the structure (Carson et al., 2007) so an influence
on the structure or the crystallization can not be ascertained. Moreover, His-tags do
not seem to have an effect on the structure as such. As a study that compared native
structures and their His-tagged counterparts showed R values and resolution are not
effected and only B-values are slightly higher for the tagged structures (Carson et al.,
2007). Why no crystals with native DCTN1412-533-IC2-47 appeared cannot be said for
sure. A reason could be the missing His-tag since DCTN1412-533-IC2-47 -His-TEV did
form crystals albeit with low resolution. Another reason could be that the crystalliza-
tion condition for the native protein has not been found yet.
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A later study by Morgan et al. (2011) found two IC binding regions. Region 1 includes
aa 1-41 of Drosophila melanogaster IC and is assumed to adopt an α-helix. Region 2
consists of aa 46-75 and is assumed to form a nascent helix with aa 48-60. Between
both regions D. melanogaster IC has several glycines (Gly41-Gly45) that disrupt he-
lices due to high conformational flexibility (Serrano et al., 1992). The transfer of this
finding led to the new DCTN1412-533-IC2-84 construct. However, after purification the
protein complex quickly precipitated. Hence, crystallization set ups were only possible
within the next 16 hours after concentration. No crystals formed with this construct.
The fast precipitation of DCTN1412-533-IC2-84 led to the consideration that the exten-
sion from 47 aa to 84 aa might have been too long. A comparison between the IC
protein sequence of D. melanogaster as used in the study and the human IC (see figure
3.5) revealed that the latter has far more prolines in region 2. Human IC contains five
prolines in the designated binding region 2 and D. melanogaster only one. Prolines are
known to disrupt the helical structure and cause kinks and breaks (Yun et al., 1991).
Due to the circular composition of proline it does not have a backbone-NH to take
part in a hydrogen bond causing a destabilization of the helix. The consequential kink
between two helices varies between 15 to 40% (Yun et al., 1991). This produces a local
flexibility in the helix, which can play an important role in the function of the protein
(Visiers et al., 2000). The analysis of human IC shows a proline (Pro45) between the
two potential binding regions which might lead to some degree of kinking between the
regions. In contrast to D. melanogaster IC region 2 of human IC could only take part
in the DCTN1 binding until aa 69 because half of the following ten residues are prolines
unlikely to take part in any binding process. Furthermore, these prolines are followed
by a disordered protein sequence stretch containing several glycines and prolines.
On these grounds, DCTN1412-533-IC2-69 was cloned that stopped right before the first
proline (Pro70) in region 2. The IC band on SDS gel after gelfiltration was more
pronounced compared to DCTN1412-533-IC2-47 indicating a better binding to DCTN1.
Crystallization resulted in the same house-like form seen in DCTN1412-533-IC2-47 and
showed no better resolution (6 Å).
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4.2. Crystallization condition could be responsible
for missing IC in crystals
The missing of bound IC on DCTN1 raised the question what could have caused the
separation of both proteins. Protein-protein interactions are established by hydrogen
bonds, electrostatics, or hydrophobic bonds. Sedimentation equilibrium experiments
carried out by Siglin et al. (2013) showed pH and salt dependence of the DCTN1-IC
complex. The complex (DCTN1278-548 and IC1-124) was most stable in 100 mM sodium
chloride, which is the same salt concentration used for dialysis and gelfiltration buffer
in this work. So, the sodium chloride concentration does not impair the DCTN1-IC
interaction. Furthermore, the complex showed the highest stability at pH 8.0 with a
dissociation constant of ≤10-14 M2 and decreases towards pH 7 and 9 (≤10-12 M2 and
≤10-12 M2, respectively). Additionally, it should be noted that dissociation constants
are also influenced by conditions like temperature and salt. Assuming that at pH 5.5
(pH of crystallization condition) the DCTN1-IC interaction will be even weaker and
ammonium sulphate (also in crystallization condition) might also have some influence
could explain the missing IC molecules in the crystal.
Apart from that, the weaker IC bands visible in SDS gels could indicate that there are
two molecular complexes in the sample. One contains both DCTN1 and IC and the
other consists only of DCTN1. The principle of gelfiltration is based on the hydro-
dynamic radius (Stokes radius 1) rather than the molecular weight (Erickson, 2009).
Because of its elongated shape the hydrodynamic radius of DCTN1412-533 is large and
the addition of IC might not influence the hydrodynamic radius at all or not much.
Because of that, in gelfiltration both complexes are eluted at the same time and it
would not be possible to distinguish them.
4.3. DCTN1412-533 forms a coiled-coil
The solved structure adopts the expected parallel dimeric left-handed coiled-coil con-
taining 14 continuous heptad motif repeats. Due to 15 SeMet positions and the suc-
cession of three alanines in the sequence (Ala485-487), which are well defined in the
electron density map of all five helices, the structure could be modelled unambiguously
into the electron density.
On average one turn in the α-helix is made up of 3.62 residues, which is close to the
typical 3.63 residues per turn (Lupas, 1996). The rise per residue (1.51 Å) is also in
1Stokes radius is the radius of a hypothetical hard sphere that has the same diffusion properties like
a protein described with the same hydrodynamic radius.
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accordance with an average coiled-coil (Phillips, 1992). The helices of the three coiled-
coils wind around each other with an average pitch of 149.9 to 158.5 Å. Therefore, they
belong to the far end of the standard pitch range of 120-160 Å (Phillips, 1992). Two
stretches, one in the N- and one in the C-terminus, display mean radii. These areas
are characterized by mainly canonical hydrophobic residues. Of more interest are two
areas found in coiled-coils A/B and C/D that are marked by a slight widening (>11 Å)
followed by a narrowing (<9 Å) of the distances between the two helices. The first
region is characterized by polar amino acids 461Asn, 468Gln, and 475Glu in position
a and Asn464 in d -position. Although buried polar residues at core positions are ther-
modynamically not favoured they are important for coiled-coil specificity (Hartmann
et al., 2009). Polar residues are known to determine the oligomerization of the leucine
zipper GCN4. For example, asparagine in position a is important for the formation
of GCN4 parallel dimers (Akey et al., 2001). Furthermore, the substitution of alanine
to glutamine or asparagine at position a in tropomyosin could show that the core is
less tightly packed (Singh and Hitchcock-DeGregori, 2003) resulting in a larger radius.
The second region is characterized by a decrease of the radius. This results from a
cluster of three alanines (Ala485, 492, 499) at position d. Clusters of alanine have
been found before in tropomyosin (Brown et al., 2001) and cortexillin (Burkhard et al.,
2000). They are associated with the aforementioned decrease of radius and a stagger
between the helices causing a bend of the coiled-coil (Brown et al., 2001). Figure 4.1
shows the alanine cluster superimposed onto a canonical leucine cluster (Leu443, 450,
457) to demonstrate the stagger as seen in Brown et al. (2001). The alanine con-
taining helices are closer together and are slightly out of register, which breaks the
2-fold symmetry seen in canonical (leucine containing) sections of DCTN1412-533 (de-
picted in green in figure 4.1). The alanine triplet is bracketed by two local bends at
residues Leu482 and Ala504/Asp505. Due to the local opposing direction of the bends
(closer to 180° apart than 0°) an in-plane bending can be assigned. While the bending
of tropomyosin can be attributed to its need to bind around actin filaments (Brown
et al., 2005) it is not clear why dynactin DCTN1 contains such a feature. The E/E’
coiled-coil is somewhat different in that it displays a larger (>6 Å) and longer deviation
from the mean radius. This results in a shorter decrease of the radius that does not
involve the whole alanine cluster. Also, no local bends could be found with CCBENDS.
The overall structure of the coiled-coils is very similar as indicated by the low r.m.s.d’s
of the whole chain superimpositions. However, superimposing only the first 29-33
amino acids of the N-terminus resulted in diverging spatial orientations of the coiled-
coils which can be attributed to the local bends found in A/B and C/D but not in
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Figure 4.1.: Cluster of three alanines cause stagger in coiled-coil. A canonical
leucine section was superimposed with the alanine cluster. It shows that the
fragment with alanine in d -positions is axially out of register and closer to the
other helix. Leucine (green lines) and alanine (blue sticks) in position d are
depicted.
E/E’. Furthermore, the rather high B-values are indicative for a highly flexible protein.
However, at the sites of crystal contact between coiled-coils the B-values are consider-
ably smaller (see figure 3.20). Studies have questioned whether B-values are actually a
predicate for protein dynamics (Halle, 2002, Radivojac et al., 2004) when crystal con-
tacts are involved. For example, myoglobin crystallized in two different crystal forms
resulting in an overall identical structure. But comparison of the B-factors showed sig-
nificant differences in parts of the structure which resulted from the different packing
constraints (Phillips, 1990). The B-factor disturbance coming from crystal contacts
are considered as one of the largest noise source in B-factors data (Radivojac et al.,
2004), which is why conclusions based on these values could be misleading.
4.4. N-terminal IC is more likely to be a single
α-helix than a coiled-coil
The first 44-67 residues of the N-terminal region of dynein intermediate chains are
predicted to form a coiled-coil. However, analyses of the coiled-coil propensity indicate
that two single α-helices are more likely. The a- and d -positions, which are mainly
apolar (75-80%) in coiled-coils (Conway and Parry, 1990), are occupied by only 35%
apolar residues in IC1-69. Instead these positions as well as other heptad positions are
filled with charged residues. A total of 56% of the residues are charged, which is in
agreement with 57% found in the CSAH of myosin 10 (Peckham and Knight, 2009). In
contrast DCTN1412-533 only contains 41% charged residues consistent with findings in
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the myosin 2 coiled-coil (Peckham and Knight, 2009). These findings favour a CSAH
for IC over a coiled-coil. This assumption can be further fortified by a recent publica-
tion by Siglin et al. (2013). Molecular weight determined by sedimentation equilibrium
analytical ultracentrifugation suggests a monomeric IC (both for IC1-44 and IC1-124).
4.5. Possible dynein-dynactin interaction models
The crosslink experiments were performed to clarify the binding location of dynein
IC on DCTN1. Based on the present results no definite conclusion can be drawn.
However, four interaction scenarios can be imagined, which are depicted in figure 4.2.
Two crosslink hotspots could be detected on DCTN1412-533, one on the N-terminus at
Lys446 (green) that is located in the negatively charged area (for surface figure see
3.23) and one on the C-terminus at Lys494 (orange) and Lys511(purple) being in a
less negatively charged region. The distance between Lys446 and Lys494 amounts to
≈71 Å which cannot be covered by two crosslinks co-existing at the same time on
the same IC molecule since one crosslink (Lys-BS3-Lys) can maximally bridge 24 Å
(Young et al., 2000). Therefore, two binding sites on DCTN1412-533 are considered.
The question is, how dynein IC binds to these sites. Considering that both the short
IC2-47, which only comprisef the first binding region (Morgan et al., 2011), and the
longer IC2-69 developed crosslinks at the N- and the C-terminus one can assume that
the two IC molecules bind separately to two different DCTN1412-533 binding sites. For
this argument it is of help to assume as discussed above that the N-terminal IC region
will not adopt a coiled-coil structure but rather bind individually to DCTN1. Because
the first 60 residues of the N-terminal IC adopt an α-helix or a nascent helix (Morgan
et al., 2011) the length of IC in the image is scaled to the length of a perfect α-helix
(1.5 Å rise per residue (Lupas and Gruber, 2005)). The IC molecules have been placed
in such a way that the first and the last possible link (according to each colour) are
each no more than 24 Å from the DCTN1 lysine apart.
There are two possible IC binding positions on both DCTN1412-533 sites. One is a par-
allel binding of the IC molecules related to the direction of the DCTN1412-533 coiled-coil
(like in figure 4.2 A). In the case of the N-terminal bound IC molecule the distance
to the first and last (Lys3 and Lys35) crosslink of IC each is 24 Å. Hence, there is
no other possible location when taking all N-terminal crosslinks into account. The
situation is different for the C-terminal parallel bound molecule. Here, the drawn-in
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Figure 4.2.: Possible dynein-dynactin interaction models. The image shows
three possible scenarios for the binding of dynein IC on DCTN1. Each
bar represents a lysine position. Same coloured lysines in IC crosslinked
to the DCTN1412-533 lysine in the same color. Bars in grey did not ex-
hibit any crosslinks. For reasons of simplicity only IC2-69 and not IC2-47 is
shown. Both proteins are drawn in the scale of a perfect α-helix. (A) Both,
the DCTN1412-533 coiled-coil and the single IC monomers bind parallel (in
the same N → C direction). (B) Both IC molecules bind anti-parallel to
DCTN1412-533. (C) One IC molecule binds parallel, the other anti-parallel to
DCTN1412-533.
molecule could be shifted towards both termini (within the 24 Å constraints). The
other possibility is anti-parallel bound IC molecules (like in figure 4.2 B). Again,there
is not much room for placing the N-terminally bound IC molecule to DCTN1412-533
because of the crosslink restraints. Of note here is the absence of some crosslinks (dark
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grey). Although not all expected crosslinks can form due to geometrical restraints it
is remarkable that -if anti-parallel binding does exist- not even one crosslink between
the three apparent proximal IC lysines (Lys41, 42, 54) and the surface Lys414 and 420
of DCTN1412-533 was found. However, the same consideration can also be applied to
the parallel C-terminal bound IC molecule (e.g. no link of Lys24-27 to DCTN1412-533
Lys494) as well as the anti-parallel C-terminal bound IC molecule (e.g. no link of
Lys24-27 to DCTN1412-533 Lys511). Furthermore, due to the cross-over crosslinks in
the anti-parallel C-terminal bound IC molecule (IC Lys52 to DCTN1 Lys494 and IC
Lys33/34 to DCTN1 Lys511) the location of the molecule could not be shifted towards
both termini as much as the parallel bound IC.
The first scenario (depicted in figure 4.2 A) shows the parallel binding of both IC2-69
molecules onto DCTN1412-533. The second possibility (figure 4.2 B) consists of the anti-
parallel binding of both IC molecules to the DCTN1412-533 coiled-coil. The last scenario
(figure 4.2 C) depicts a parallel/anti-parallel binding. It is twofold as the IC molecule
on the N-terminus can bind both ways and the molecule on the C-terminus in each case
binds the opposite way. In order to estimate which interaction scenario is most suitable
the (minimal and maximal) distance between the two C-termini of the IC molecules
can be compared. For the function of the whole IC molecule it is vital that the two
molecules are not too far apart since they both bind the dynein light chain Tctex-1
starting at residue Leu124 (Mok et al., 2001). So, after less than 60 residues both
molecules have to be in close enough proximity (≈20 Å, average distance between the
two IC molecules when bound to Tctex-1) to bind to Tctex-1. Applying this criterion
to the four possibilities shows that the second parallel/anti-parallel scenario with IC
C-terminal distances of ≈163-192 Å cannot fulfil it. Although it is not possible to de-
termine the length of the disordered section (aa70-123) it is unlikely that about 190 Å
are bridged by a disordered region to come into close proximity for binding Tctex-
1. The C-termini in the anti-parallel scenario have to traverse ≈108-117Å , which is
about the length of the bound IC molecule. This is more likely but it still seems a very
large distance to cross before binding to the protein. However, the parallel (15-49 Å)
and the first parallel/anti-parallel (7-15 Å) scenario could certainly bridge the distance.
In this dissertation the structure of the dimeric DCTN1412-533 could be solved. It
exhibits a canonical coiled-coil structure which features a mainly negatively charged
surface. An electrostatical interaction of these dynactin regions with two separately
binding dynein ICs is probable. Due to cross-linking experiments the localization of
the interaction site could be further refined compared to previous studies.
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A. Composition of solutions
A.1. SDS-PAGE
For the separation of differently sized proteins SDS-PAGE gels were used (modified
after Laemmli (1970)). Depending on the size of the proteins to be separated the per-
centage of acrylamide was varied. Low percentage gels are needed for high molecular
weight proteins, whereas high percentage gels give a better resolution for smaller pro-
teins.
Table A.1.: Different SDS-PAGE gel compositions
Separating gel Stacking gel
12.5% 15% 17.5% 4%
Rotiphorese(R) Gel 30 (37.5:1) 4.2 ml 5 ml 5.9 ml 0.67 ml
Buffer* 2.5 ml 2.5 ml 2.5 ml 1.25 ml
10% SDS-solution 100 µl 100 µl 100 µl 50 µl
TEMED 10 µl 10 µl 10 µl 5 µl
10% Ammonium persulfate 100 µl 100 µl 100 µl 35 µl
dH2O 3.09 ml 2.29 ml 1.39 ml 3 ml
* Buffers vary depending on the gel. Separating gel: For 12.5 and 15% gels 1.5 M Tris
buffer (pH 8.8) was used, whereas for 17.5% gels 2 M Tris buffer (pH 8.8) was needed to get a
better resolution for small proteins. Stacking gels: Here,the buffer was composed of 0.5 M
Tris at pH 6.8.
Gels were cast between two glass plates (BioRad). First the separating gel was poured
between the plates and covered with water until it was polymerized. Then, the water
was removed from the separating gel, before being covered with the stacking gel. A
plastic comb was quickly put in the stacking gel to create pockets for the protein sam-
ples.
Gels were put into a electrophoresis system (BioRad) and the container filled with
running buffer. Protein samples were mixed with SDS sample buffer and applied into
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Completely dissolved in about 800 ml dH2O and then added dH2O up to 1 liter.
A.2. SDS sample buffer
The SDS sample buffer was added to the protein samples to denature their secondary
structure and making them negatively charged. Due to the bromophenol blue dye a
tracking of the sample through the SDS gels was possible. The sample buffer was di-
luted 1:5 with the protein sample.
6× Sample buffer:






SDS-PAGE gels were stained with a Coomassie staining solution to visualise protein
bands (Fairbanks et al., 1971). To do so, the gel was placed into a small plastic box,
covered with the staining solution and put in the microwave for 30 to 90 sec on high
power. Then, the staining solution was removed and the gel was washed with water
several times to remove excess Coomassie solution. Finally, the gel was covered in de-
staining solution and placed in a microwave for 3 to 4 min on high power to visualise
the bands.
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A.4. Determining protein concentration with Bradford
Table A.2.: Buffers for SDS-PAGE staining
Coomassie staining solution Destaining solution
2.2 g Coomassie Brilliant Blue G250 (Roth) 10% Acetic acid
100 ml Acetic acid
250 ml Isopropyl alcohol
650 ml Water
A.4. Determining protein concentration with
Bradford
In order to determine the protein concentration (Bradford, 1976) a calibration line us-
ing varying BSA (bovine serum albumin) concentrations (0.2-1 mg/ml) was prepared.
20 µl of each concentration was mixed with 980 µl Bradford solution, incubated for
5 min and measured at 595 nm. Each concentration was measured three times. The
absorbance was plotted against the BSA concentration and the equation of the line
was determined. The equation was rearranged to solve unknown concentrations.
For the determination of the concentration of a protein 0.5-2 µl of the sample were
mixed with water to a total volume of 20 µl. This was added to 980 µl Bradford
solution and incubated for 5 min. The absorbance was measured at a wavelength of
595 nm and then together with the dilution factor implemented into the rearranged
equation to calculate the protein concentration.
Table A.3.: Composition of Bradford solution
100 mg Coomassie Brilliant Blue G250 (Roth)
}
dissolved over night and
filtered through a filter paper50 ml Ethanol
then the following solutions were added:





The plasmid pRSFmD1mako is used for tandem gene expression. It consists of two
multiple cloning sites (MCS) each having a 6x-His tag and a T7-promoter. For selec-
tion it has a kanamycine resistance cassette.
Figure B.1.: pRSFmD1mako vector map
85

C. Additional result files
C.1. Helical wheel representation of DCTN1412-533
Figure C.1.: Helical wheel representation of DCTN1412-533 . Charged amino
acids are coloured in red (acidic) and blue (alkaline). Polar, uncharged
amino acids are coloured in orange. Created with DrawCoil 1.0 (http:
//www.grigoryanlab.org/drawcoil/).
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C. Additional result files
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IC
Figure C.2.: Intramolecular cross-links found in IC2-69. For each found cross-
link an example fragmentation spectra is shown. Next to each spectra the
cross-linked lysines are listed together with the peptide sequences and the
cross-link site.
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Figure C.3.: Intermolecular cross-links found between IC and the N-
terminal DCTN1412-533. For each found cross-link an example fragmen-
tation spectra is shown. Next to each spectra the cross-linked lysines are
listed together with the peptide sequences and the cross-link site.
89























               
3     7               13 14                    242527     32 33 34          41 42     54





Figure C.4.: Intermolecular cross-links found between IC and the middle
section of DCTN1412-533. For each found cross-link an example frag-
mentation spectra is shown. Next to each spectra the cross-linked lysines are
listed together with the peptide sequences and the cross-link site.
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Figure C.5.: Intermolecular cross-links found between IC and the C-
terminal DCTN1412-533. For each found cross-link an example fragmen-
tation spectra is shown. Next to each spectra the cross-linked lysines are
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